Samyang Holdings Corporation

Republic of Korea

Back to Profile

1-100 of 211 for Samyang Holdings Corporation Sort by
Query
Aggregations
IP Type
        Patent 125
        Trademark 86
Jurisdiction
        United States 99
        World 56
        Canada 52
        Europe 4
Date
New (last 4 weeks) 2
2025 April (MTD) 1
2025 March 4
2025 February 11
2024 December 26
See more
IPC Class
A61K 9/00 - Medicinal preparations characterised by special physical form 26
A61K 9/51 - Nanocapsules 25
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers 15
A61K 9/107 - Emulsions 14
A61K 9/16 - AgglomeratesGranulatesMicrobeadlets 14
See more
NICE Class
10 - Medical apparatus and instruments 24
05 - Pharmaceutical, veterinary and sanitary products 19
01 - Chemical and biological materials for industrial, scientific and agricultural use 11
19 - Non-metallic building materials 8
30 - Basic staples, tea, coffee, baked goods and confectionery 7
See more
Status
Pending 55
Registered / In Force 156
  1     2     3        Next Page

1.

SAMYANG

      
Application Number 1850358
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 11 - Environmental control apparatus

Goods & Services

Waste water treatment apparatus for household purposes; reverse osmosis water purification units; water purification installations for waterworks; reactor for water treatment; membrane filtration units for water treatment apparatus; reverse osmosis membrane filters for water treatment; membranes for reverse osmosis units; ion exchange apparatus for water and air purification; waste water treatment devices; waste water treatment tanks.

2.

SAMYANG

      
Application Number 1844877
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Medical apparatus for injecting fillers for plastic surgery; surgical apparatus and instruments for veterinary use; veterinary apparatus; liquid medicine syringes; devices for injecting pharmaceuticals; surgical instruments and apparatus; surgical apparatus and instruments for medical, dental or veterinary use; medical instruments; medical apparatus and instruments other than for dental purposes; medical apparatus and instruments; surgical and medical apparatus and instruments; injectors for medical purposes; medical injection syringe; diagnostic apparatus for medical purposes; medical apparatus for injecting fillers; syringes for injection of medical substances; medical apparatus and instruments for administering pharmaceuticals; injection needles; syringes for injections; skin stimulation apparatus for therapeutic purposes; dermatological apparatus for injecting fillers; skin regeneration therapy apparatus; medical apparatus for skin wrinkle removal; medical apparatus and instruments for the treatment of skin; sutures; medical apparatus for tissue adhesives for use in surgery; surgical mesh comprised primarily of artificial materials; medical apparatus for preventing adhesion; thread for medical use.

3.

SAMYANG

      
Application Number 1843965
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 35 - Advertising and business services

Goods & Services

Retail store services featuring unprocessed artificial resins for 3D printers; business assistance, management and information services; retail store services featuring surface-active chemical agents; business advice and information relating to customer relationship management (CRM); retail store services featuring downloadable computer software for use in customer relationship management (CRM); customer relationship management; retail store services featuring fruit juices; advertising and marketing; retail store services featuring unprocessed light curing resins; retail store services featuring wheat flour; retail store services featuring biscuit mixes; retail store services featuring hangover remedies with vitamin C containing yeast-based ingredients for medical purposes; organisation of exhibitions and events for commercial or advertising purposes; promoting the goods and services of others; provision of an online marketplace for buyers and sellers of goods and services; retail store services featuring reverse osmosis membrane filters for water treatment; retail store services featuring non-alcoholic beverages for prevention of hangover, not for medical purposes; retail store services featuring functional beverages against hangover, not for medical purposes; retail store services featuring starch for food; retail store services featuring drug delivery agents; retail store services featuring oligosaccharides for culinary purposes; retail store services featuring medical apparatus and instruments; retail store services featuring fillers for medical use [pharmaceutical preparations]; retail store services featuring medical apparatus for injecting fillers; retail store services featuring medicinal drinks; retail store services featuring pharmaceuticals; retail store services featuring ion exchange resins [chemical preparations]; retail store services featuring ion exchangers [chemical preparations]; retail store services featuring downloadable enterprise software for enterprise resource planning (ERP); arranging of contracts for the purchase and sale of goods and services, for others; retail store services featuring beverages made of tea; retail store services featuring coffee; retail store services featuring polyethtylene terephthalate resins; retail store services featuring processed food products against hangover mainly based on hovenia dulcis extract, not for medical purposes; retail store services featuring processed red ginseng products; retail store services featuring cosmetics; retail store services featuring food products against hangover consisting primarily of yeast, not for medical purposes.

4.

SAMYANG

      
Application Number 1842718
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Unprocessed plastics for 3D printers; photocurable unprocessed artificial resins for 3D printers; unprocessed acrylic resins for 3D printers; unprocessed artificial resins for 3D printers; sensitized paper; surface-active chemical agents; polymeric adsorbents; unprocessed plastics for industrial use; ultraviolet light-curable composite materials for engineering purposes; chemical additives for industrial purposes for photocurable unprocessed resins; photocurable unprocessed polymethyl methacrylate resins; meta acryl polymer; unprocessed plastics in all forms; photocurable unprocessed synthetic resins; unprocessed light curing resins; unprocessed plastics; unprocessed synthetic resins; recalling agents using biomass for industrial purposes; ion exchange resins [chemical preparations]; ion exchangers [chemical preparations]; polymerization plastics; catalysts; chemicals for use in the treatment of waste water; waste water treatment agents; unprocessed photocurable resin compositions containing polymers; polyethtylene terephthalate resins; polycarbonate resins; chemical preparations for use in the manufacture of plastics; chemical adsorbents; alcohol for industrial purposes; phenol for industrial purposes; flavonoids [phenolic compounds] for industrial purposes; nitroaminophenol; nitrotoluene; nitrophenol; methyl alcohol; benzyl alcohol; bisphenol A; phenols; adhesives for industrial purposes; chemical additives for industrial purposes; photocatalysts; unprocessed polyurethane; unprocessed polyurethane resins; moistening agents; unprocessed silicone resins; water softening agents; emulsifiers; metallic oxides for photoresist processes; photoresists; chemical thickening agents for use in the manufacture of cosmetic products.

5.

SAMYANG

      
Application Number 1842109
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 29 - Meat, dairy products, prepared or preserved foods

Goods & Services

Processed food products against hangover mainly based on pueraria extract, not for medical purposes; processed food products against hangover mainly based on licorice extract, not for medical purposes; processed food products against hangover mainly based on fruit and vegetable extracts, not for medical purposes; frozen red ginseng for use as a vegetable; processed food products against hangover mainly based on yam extract, not for medical purposes; fermented processed red ginseng for use as a vegetable; processed food products against hangover mainly based on bean sprout extract, not for medical; processed food products against hangover mainly based on hovenia dulcis extract, not for medical purposes; processed red ginseng products for use as a vegetable; red ginseng powders being processed vegetables; red ginseng jeolpyeon [sliced Korean red ginseng]; red ginseng jelly for food purposes; processed oils and fats (for food); vegetable oils and fats (for food); perilla oil for food; peanut oil for food; corn oil for food; sesame oil for food; soya bean oil for food; sunflower oil for food; olive oil for food; canola oil for food.

6.

SAMYANG

      
Application Number 1841253
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for health care; vaccines; food supplements; hangover remedies with vitamin B1 containing yeast-based ingredients for medical purposes; hangover remedies with vitamin B2 containing yeast-based ingredients for medical purposes; hangover remedies with vitamin C containing yeast-based ingredients for medical purposes; vitamin and mineral dietary supplements; veterinary substances and preparations; medicinal preparations for the mouth in the form of drops, capsules, tablets or compressed tablets; drug delivery agents; filled syringes for medical purposes [containing pharmaceuticals]; ointments for pharmaceutical purposes; cachets for pharmaceutical purposes; pharmaceutical preparations being hormone preparations for human use; pills for pharmaceutical purposes; ferments for pharmaceutical purposes; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drugs for medical purposes; pre-filled syringes for medical purposes; skin anti-aging preparations for medical use; fillers for medical use [pharmaceutical preparations]; pharmaceutical syringes prefilled with medical hyaluronic acid as the main ingredient; medicinal drinks; pharmaceutical drugs; medicinal infusions; pharmaceuticals; human vaccine preparations; medicines for human purposes; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements; pharmaceutical preparations; pharmaceutical preparations for wrinkle treatment; injectable pharmaceutical preparations for filling wrinkle in the form of gel; injectable dermal fillers; implantable medicines; nutraceutical preparations for therapeutic or medical purposes; dermatological pharmaceutical products; solutions for dermatological use; pharmaceutical preparations for use in dermatology, namely, injectable dermatological fillers; pharmaceutical preparations for skin whitening; pharmaceutical preparations for skin moisturizing; injectable pharmaceutical preparations for skin moisturizing; pharmaceutical preparations for skin care; pharmaceutical preparations for skin regeneration; antibiotics; nicotine patches for use as aids to stop smoking; pharmaceutical preparations used in the smoking cessation; anti-adhesion agents for medical purposes; surgical glues; denture adhesives; dental adhesives; medical adhesives for binding internal tissue; medical adhesives for binding wounds; hemostatics for medical purposes; transdermal patches for medical treatment; haemostatic preparations; anti-cancer preparations.

7.

SAMYANG

      
Application Number 1842039
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 41 - Education, entertainment, sporting and cultural services

Goods & Services

Planning of entertainment performances; planning of performance events; educational services; arranging and conducting of seminars, conferences and exhibitions for cultural or educational purposes; organization of shows for cultural purposes; nursery school services; distance learning services provided on-line; distance learning services; kindergarten services; fitness and exercise club services.

8.

SAMYANG

      
Application Number 1840383
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer software for use in customer relationship management (CRM); software for commerce over a global communications network; downloadable software as a medical device [SaMD]; downloadable instant messaging software; downloadable computer software for use as a digital wallet; interactive multimedia computer programs; data processing software; computer software for database management; financial management software; downloadable enterprise software for enterprise resource planning (ERP); computer software to maintain and operate a computer system; computer e-commerce software; protective helmets; foldable protective helmets; crash helmets.

9.

SAMYANG

      
Application Number 1840384
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Development of computer software for data processing; research and development of vaccines and medicines; inspection of foodstuffs for quality control; inspection of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research services; services for assessing the efficiency of pharmaceuticals; medical laboratories; medical research laboratory services; scientific research for medical purposes; medicine research; analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection, and research of medical products; consultancy in the field of testing, inspection, research of medical products; biopsy for medical research; blood testing for medical research; blood collection for medical research; engineer services in the field of medical technology; computer software development; cloud computing services; technical research in the field of semiconductor manufacturing; research services relating to semiconductors; drug discovery services; development of pharmaceutical preparations and medicines.

10.

NANOPARTICLE COMPOSITION FOR PULMONARY DRUG DELIVERY

      
Application Number 18722663
Status Pending
Filing Date 2022-12-23
First Publication Date 2025-02-20
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Yoo, Seung Ju
  • Park, Jong Min
  • Jeong, Seung Wei

Abstract

The present invention relates to a nanoparticle composition for pulmonary drug delivery and, more specifically, to a drug delivery composition useful for specifically delivering a drug into the lungs, wherein the drug delivery composition comprises drug-bearing nanoparticles in which a complex of an anionic drug and a specific lipid is encapsulated inside nanoparticles formed by an amphiphilic block copolymer.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/51 - Nanocapsules
  • A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit

11.

LIPIDS FOR DRUG DELIVERY, NANOPARTICLES COMPRISING SAME, AND COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES

      
Application Number 18723272
Status Pending
Filing Date 2022-12-23
First Publication Date 2025-02-20
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Jong Min
  • Nam, Joung Pyo
  • Nam, Hye Yeong
  • Lee, So Jin
  • Kyung, Kyu Jin
  • Yoon, Yoo Jeong

Abstract

The present invention relates to lipids for drug delivery, nanoparticles comprising same, and a composition for drug delivery comprising the nanoparticles. More specifically, the present invention relates to: lipids useful for drug delivery since the lipids can easily form a complex with an anionic drug due to a specific structure thereof, and the complex can be encapsulated inside nanoparticles formed by an amphiphilic block copolymer; nanoparticles comprising same; and a composition for drug delivery comprising the lipids and a composition for drug delivery comprising the nanoparticles.

IPC Classes  ?

  • A61K 9/127 - Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
  • A61K 9/51 - Nanocapsules
  • C07C 231/14 - Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
  • C07C 237/16 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated

12.

SAMYANG

      
Application Number 1837954
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 30 - Basic staples, tea, coffee, baked goods and confectionery

Goods & Services

Flour mixes; crystal sugar [not confectionery]; maltose; wheat flour; biscuit mixes; mixes for the preparation of bread; sugar; starch for food; glucose for food; fructose for food; liquid fructose; oligosaccharides for culinary purposes; glucose for culinary purposes; raw sugar; grain syrup; palm sugar; beverages made of tea; natural sweeteners; coffee; cookie mixes; fructo-oligosaccharide for culinary purposes; food products for prevention of hangover consisting primarily of yeast, not for medical purposes; food products consisting primarily of yeast, not for medical purposes; food products against hangover consisting primarily of yeast, not for medical purposes; cube sugar; treacle; royal jelly; natural sweeteners, in particular allulose for culinary purposes; sugar substitutes for culinary purposes.

13.

SAMYANG

      
Application Number 1837489
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 39 - Transport, packaging, storage and travel services

Goods & Services

Delivery services; storage; transport, delivery, packaging, and storage of goods; transportation of goods; wrapping of goods; transport, delivery, packaging, and storage of food and beverages; locating and tracking of people for transportation purposes; providing transportation information; warehousing; supply chain logistics and reverse logistics services consisting of the storage, transportation and delivery of goods for others by air, rail, ship or truck.

14.

SAMYANG

      
Application Number 1837490
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 32 - Beers; non-alcoholic beverages

Goods & Services

Non-alcoholic beverages for prevention of hangover consisting primarily of pueraria extract, not for medical purposes; functional beverages against hangover consisting primarily of pueraria extract, not for medical purposes; non-alcoholic beverages for hangover prevention consisting primarily of curcumin extracted from turmeric, not for medical purposes; fruit juices; protein-enriched sports beverages; powders for effervescing beverages; pastilles for effervescing beverages; syrups for making non-alcoholic beverages; beverages, non-alcoholic; non-alcoholic beverages, namely isotonic drinks containing electrolytes; vitamin enriched water [beverages]; waters [beverages]; non-alcoholic beverages for prevention of hangover, not for medical purposes; functional beverages against hangover, not for medical purposes; mineral water [beverages] against hangover, not for medical purposes; water [beverages] against hangover, not for medical purposes; drinks containing amino acid; functional non-alocholic beverages, namely hangover-relieving beverages to alliviate hangover symptoms, not for medical purposes; energy drinks; soft drinks; functional non-alcoholic beverages, namely, hangover-relieving beverages to help decrease alcohol levels in the body, not for medical purposes; non-alcoholic beverages for hangover prevention consisting primarily of hovenia dulcis fruit extract, not for medical purposes; functional beverages against hangover consisting primarily of hovenia dulcis fruit extract, not for medical purposes; red ginseng drinks; non-alcoholic beverages for hangover prevention consisting primarily of yeast extracts, not for medical purposes; functional beverages against hangover consisting primarily of yeast extracts, not for medical purposes.

15.

SAMYANG

      
Application Number 1837488
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations

Goods & Services

Sheet masks for neck [cosmetics]; make-up; pores tightening mask packs used as cosmetics; cosmetic preparations for the hair and scalp; pre-moistened cleansing tissues; beauty creams; body and beauty care cosmetics; body creams; body cleanser; shampoos; sun block [cosmetics]; sunscreen preparations; toiletry preparations; skin lotions; cosmetic preparations for skin care; essential oils; facial cleansers; skin cleansing foams; hair care preparations; mask packs for cosmetic purposes; cotton wool and cotton tip sticks for cosmetic purposes; cosmetic facial masks; make-up removing preparations; tissues impregnated with cosmetics; cosmetics.

16.

SAMYANG

      
Application Number 1837491
Status Registered
Filing Date 2024-12-18
Registration Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 38 - Telecommunications services

Goods & Services

Electronic transmission and streaming of digital media content for others via global and local computer networks; electronic exchange of messages via chat lines, chatrooms and Internet forums; transmission of data, audio, video and multimedia files; digital media streaming services; providing access to multimedia content on-line; transmission of messages and images; electronic messaging services; text messaging services; instant messaging services; wireless digital messaging services; telephone voice messaging services; virtual chatrooms established via text messaging; providing online forums for the transmission of messages, comments and multimedia content among users; instant messenger service for shopping information service; messaging services of smart phone applications; providing access to online community sites via smartphone applications; transmission of mobile content via a smart phone; providing access to online chat rooms and electronic bulletin boards; streaming of audio and video content over the internet and wireless networks; audio and video broadcasting services over the Internet; broadcasting of audiovisual and multimedia content via the Internet; electronic bulletin board services that enable connection to a variety of thematic information and opinions via internet; provision of telecommunication access to viewing video of museums and exhibitions via telepresence robot; videoconferencing services.

17.

SAMYANG

      
Application Number 237988900
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 30 - Basic staples, tea, coffee, baked goods and confectionery

Goods & Services

(1) Flour mixes; crystal sugar [not confectionery]; maltose; wheat flour; biscuit mixes; mixes for the preparation of bread; sugar; starch for food; glucose for food; fructose for food; liquid fructose; oligosaccharides for culinary purposes; glucose for culinary purposes; raw sugar; grain syrup; palm sugar; beverages made of tea; natural sweeteners; coffee; cookie mixes; fructo-oligosaccharide for culinary purposes; food products for prevention of hangover consisting primarily of yeast, not for medical purposes; food products consisting primarily of yeast, not for medical purposes; food products against hangover consisting primarily of yeast, not for medical purposes; cube sugar; treacle; royal jelly; natural sweeteners, in particular allulose for culinary purposes; sugar substitutes for culinary purposes.

18.

SAMYANG

      
Application Number 238266300
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

(1) Downloadable computer software for use in customer relationship management (CRM); software for commerce over a global communications network; downloadable software as a medical device [SaMD]; downloadable instant messaging software; downloadable computer software for use as a digital wallet; interactive multimedia computer programs; data processing software; computer software for database management; financial management software; downloadable enterprise software for enterprise resource planning (ERP); computer software to maintain and operate a computer system; computer e-commerce software; protective helmets; foldable protective helmets; crash helmets.

19.

SAMYANG

      
Application Number 238266100
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for health care; vaccines; food supplements; hangover remedies with vitamin B1 containing yeast-based ingredients for medical purposes; hangover remedies with vitamin B2 containing yeast-based ingredients for medical purposes; hangover remedies with vitamin C containing yeast-based ingredients for medical purposes; vitamin and mineral dietary supplements; veterinary substances and preparations; medicinal preparations for the mouth in the form of drops, capsules, tablets or compressed tablets; drug delivery agents; filled syringes for medical purposes [containing pharmaceuticals]; ointments for pharmaceutical purposes; cachets for pharmaceutical purposes; pharmaceutical preparations being hormone preparations for human use; pills for pharmaceutical purposes; ferments for pharmaceutical purposes; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drugs for medical purposes; pre-filled syringes for medical purposes; skin anti-aging preparations for medical use; fillers for medical use [pharmaceutical preparations]; pharmaceutical syringes prefilled with medical hyaluronic acid as the main ingredient; medicinal drinks; pharmaceutical drugs; medicinal infusions; pharmaceuticals; human vaccine preparations; medicines for human purposes; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements; pharmaceutical preparations; pharmaceutical preparations for wrinkle treatment; injectable pharmaceutical preparations for filling wrinkle in the form of gel; injectable dermal fillers; implantable medicines; nutraceutical preparations for therapeutic or medical purposes; dermatological pharmaceutical products; solutions for dermatological use; pharmaceutical preparations for use in dermatology, namely, injectable dermatological fillers; pharmaceutical preparations for skin whitening; pharmaceutical preparations for skin moisturizing; injectable pharmaceutical preparations for skin moisturizing; pharmaceutical preparations for skin care; pharmaceutical preparations for skin regeneration; antibiotics; nicotine patches for use as aids to stop smoking; pharmaceutical preparations used in the smoking cessation; anti-adhesion agents for medical purposes; surgical glues; denture adhesives; dental adhesives; medical adhesives for binding internal tissue; medical adhesives for binding wounds; hemostatics for medical purposes; transdermal patches for medical treatment; haemostatic preparations; anti-cancer preparations.

20.

SAMYANG

      
Application Number 238418100
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 29 - Meat, dairy products, prepared or preserved foods

Goods & Services

(1) Processed food products against hangover mainly based on pueraria extract, not for medical purposes; processed food products against hangover mainly based on licorice extract, not for medical purposes; processed food products against hangover mainly based on fruit and vegetable extracts, not for medical purposes; frozen red ginseng for use as a vegetable; processed food products against hangover mainly based on yam extract, not for medical purposes; fermented processed red ginseng for use as a vegetable; processed food products against hangover mainly based on bean sprout extract, not for medical; processed food products against hangover mainly based on hovenia dulcis extract, not for medical purposes; processed red ginseng products for use as a vegetable; red ginseng powders being processed vegetables; red ginseng jeolpyeon [sliced Korean red ginseng]; red ginseng jelly for food purposes; processed oils and fats (for food); vegetable oils and fats (for food); perilla oil for food; peanut oil for food; corn oil for food; sesame oil for food; soya bean oil for food; sunflower oil for food; olive oil for food; canola oil for food.

21.

SAMYANG

      
Application Number 237848600
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 39 - Transport, packaging, storage and travel services

Goods & Services

(1) Delivery services; storage; transport, delivery, packaging, and storage of goods; transportation of goods; wrapping of goods; transport, delivery, packaging, and storage of food and beverages; locating and tracking of people for transportation purposes; providing transportation information; warehousing; supply chain logistics and reverse logistics services consisting of the storage, transportation and delivery of goods for others by air, rail, ship or truck.

22.

SAMYANG

      
Application Number 238562000
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 35 - Advertising and business services

Goods & Services

(1) Retail store services featuring unprocessed artificial resins for 3D printers; business assistance, management and information services; retail store services featuring surface-active chemical agents; business advice and information relating to customer relationship management (CRM); retail store services featuring downloadable computer software for use in customer relationship management (CRM); customer relationship management; retail store services featuring fruit juices; advertising and marketing; retail store services featuring unprocessed light curing resins; retail store services featuring wheat flour; retail store services featuring biscuit mixes; retail store services featuring hangover remedies with vitamin C containing yeast-based ingredients for medical purposes; organisation of exhibitions and events for commercial or advertising purposes; promoting the goods and services of others; provision of an online marketplace for buyers and sellers of goods and services; retail store services featuring reverse osmosis membrane filters for water treatment; retail store services featuring non-alcoholic beverages for prevention of hangover, not for medical purposes; retail store services featuring functional beverages against hangover, not for medical purposes; retail store services featuring starch for food; retail store services featuring drug delivery agents; retail store services featuring oligosaccharides for culinary purposes; retail store services featuring medical apparatus and instruments; retail store services featuring fillers for medical use [pharmaceutical preparations]; retail store services featuring medical apparatus for injecting fillers; retail store services featuring medicinal drinks; retail store services featuring pharmaceuticals; retail store services featuring ion exchange resins [chemical preparations]; retail store services featuring ion exchangers [chemical preparations]; retail store services featuring downloadable enterprise software for enterprise resource planning (ERP); arranging of contracts for the purchase and sale of goods and services, for others; retail store services featuring beverages made of tea; retail store services featuring coffee; retail store services featuring polyethtylene terephthalate resins; retail store services featuring processed food products against hangover mainly based on hovenia dulcis extract, not for medical purposes; retail store services featuring processed red ginseng products; retail store services featuring cosmetics; retail store services featuring food products against hangover consisting primarily of yeast, not for medical purposes.

23.

SAMYANG

      
Application Number 237848800
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 32 - Beers; non-alcoholic beverages

Goods & Services

(1) Non-alcoholic beverages for prevention of hangover consisting primarily of pueraria extract, not for medical purposes; functional beverages against hangover consisting primarily of pueraria extract, not for medical purposes; non-alcoholic beverages for hangover prevention consisting primarily of curcumin extracted from turmeric, not for medical purposes; fruit juices; protein-enriched sports beverages; powders for effervescing beverages; pastilles for effervescing beverages; syrups for making non-alcoholic beverages; beverages, non-alcoholic; non-alcoholic beverages, namely isotonic drinks containing electrolytes; vitamin enriched water [beverages]; waters [beverages]; non-alcoholic beverages for prevention of hangover, not for medical purposes; functional beverages against hangover, not for medical purposes; mineral water [beverages] against hangover, not for medical purposes; water [beverages] against hangover, not for medical purposes; drinks containing amino acid; functional non-alocholic beverages, namely hangover-relieving beverages to alliviate hangover symptoms, not for medical purposes; energy drinks; soft drinks; functional non-alcoholic beverages, namely, hangover-relieving beverages to help decrease alcohol levels in the body, not for medical purposes; non-alcoholic beverages for hangover prevention consisting primarily of hovenia dulcis fruit extract, not for medical purposes; functional beverages against hangover consisting primarily of hovenia dulcis fruit extract, not for medical purposes; red ginseng drinks; non-alcoholic beverages for hangover prevention consisting primarily of yeast extracts, not for medical purposes; functional beverages against hangover consisting primarily of yeast extracts, not for medical purposes.

24.

SAMYANG

      
Application Number 238701800
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

(1) Medical apparatus for injecting fillers for plastic surgery; surgical apparatus and instruments for veterinary use; veterinary apparatus; liquid medicine syringes; devices for injecting pharmaceuticals; surgical instruments and apparatus; surgical apparatus and instruments for medical, dental or veterinary use; medical instruments; medical apparatus and instruments other than for dental purposes; medical apparatus and instruments; surgical and medical apparatus and instruments; injectors for medical purposes; medical injection syringe; diagnostic apparatus for medical purposes; medical apparatus for injecting fillers; syringes for injection of medical substances; medical apparatus and instruments for administering pharmaceuticals; injection needles; syringes for injections; skin stimulation apparatus for therapeutic purposes; dermatological apparatus for injecting fillers; skin regeneration therapy apparatus; medical apparatus for skin wrinkle removal; medical apparatus and instruments for the treatment of skin; sutures; medical apparatus for tissue adhesives for use in surgery; surgical mesh comprised primarily of artificial materials; medical apparatus for preventing adhesion; thread for medical use.

25.

SAMYANG

      
Application Number 238418200
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

(1) Unprocessed plastics for 3D printers; photocurable unprocessed artificial resins for 3D printers; unprocessed acrylic resins for 3D printers; unprocessed artificial resins for 3D printers; sensitized paper; surface-active chemical agents; polymeric adsorbents; unprocessed plastics for industrial use; ultraviolet light-curable composite materials for engineering purposes; chemical additives for industrial purposes for photocurable unprocessed resins; photocurable unprocessed polymethyl methacrylate resins; meta acryl polymer; unprocessed plastics in all forms; photocurable unprocessed synthetic resins; unprocessed light curing resins; unprocessed plastics; unprocessed synthetic resins; recalling agents using biomass for industrial purposes; ion exchange resins [chemical preparations]; ion exchangers [chemical preparations]; polymerization plastics; catalysts; chemicals for use in the treatment of waste water; waste water treatment agents; unprocessed photocurable resin compositions containing polymers; polyethtylene terephthalate resins; polycarbonate resins; chemical preparations for use in the manufacture of plastics; chemical adsorbents; alcohol for industrial purposes; phenol for industrial purposes; flavonoids [phenolic compounds] for industrial purposes; nitroaminophenol; nitrotoluene; nitrophenol; methyl alcohol; benzyl alcohol; bisphenol A; phenols; adhesives for industrial purposes; chemical additives for industrial purposes; photocatalysts; unprocessed polyurethane; unprocessed polyurethane resins; moistening agents; unprocessed silicone resins; water softening agents; emulsifiers; metallic oxides for photoresist processes; photoresists; chemical thickening agents for use in the manufacture of cosmetic products.

26.

SAMYANG

      
Serial Number 79416318
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations

Goods & Services

Sheet masks for neck for cosmetic purposes, namely, cosmetic masks; make-up; pores tightening mask packs used as cosmetics; cosmetic preparations for the hair and scalp; pre-moistened cleansing tissues impregnated with a skin cleanser; beauty creams; body and beauty care cosmetics; body creams; skin cleanser preparations for body; shampoos; sun block; cosmetic sunscreen preparations; non-medicated toiletry preparations; skin lotions; cosmetic preparations for skin care; essential oils; facial cleansers; skin cleansing foams; hair care preparations; mask packs for cosmetic purposes; cotton wool and cotton tip sticks for cosmetic purposes; cosmetic facial masks; make-up removing preparations; tissues impregnated with cosmetic lotions; cosmetics.

27.

SAMYANG

      
Serial Number 79416320
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 32 - Beers; non-alcoholic beverages

Goods & Services

Non-alcoholic beverages for prevention of hangover consisting primarily of pueraria extract, not for medical purposes; functional beverages against hangover consisting primarily of pueraria extract, not for medical purposes; non-alcoholic beverages for hangover prevention consisting primarily of curcumin extracted from turmeric, not for medical purposes; fruit juices; protein-enriched sports beverages; powders for effervescing beverages, namely, powders used in the preparation of soft drinks; pastilles for effervescing beverages; syrups for making non-alcoholic fruit-flavored beverages; non-alcoholic water-based beverages; non-alcoholic beverages, namely isotonic drinks containing electrolytes; vitamin enriched water being beverages, not for medical purposes; bottled drinking water; non-alcoholic beverages for prevention of hangover, not for medical purposes; functional beverages against hangover, not for medical purposes; non-alcoholic beverages, namely, mineral water against hangover, not for medical purposes; non-alcoholic beverages, namely, water against hangover, not for medical purposes; sports drinks containing amino acid; functional non-alocholic beverages, namely hangover-relieving beverages to alliviate hangover symptoms, not for medical purposes; energy drinks; soft drinks; functional non-alcoholic beverages, namely, hangover-relieving beverages to help decrease alcohol levels in the body, not for medical purposes; non-alcoholic beverages for hangover prevention consisting primarily of hovenia dulcis fruit extract, not for medical purposes; functional beverages against hangover consisting primarily of hovenia dulcis fruit extract, not for medical purposes; non-alcoholic beverages containing red ginseng juice; non-alcoholic beverages for hangover prevention consisting primarily of yeast extracts, not for medical purposes; functional beverages against hangover consisting primarily of yeast extracts, not for medical purposes

28.

SAMYANG

      
Serial Number 79416321
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 38 - Telecommunications services

Goods & Services

Electronic transmission and streaming of digital media content for others via global and local computer networks; electronic exchange of messages via chat lines, chatrooms and Internet forums; transmission of data, audio, video and multimedia files; digital media streaming services; providing access to multimedia content on-line; computer-aided transmission of messages and images; electronic messaging services; text messaging services; instant messaging services; wireless digital messaging services; telephone voice messaging services; virtual chatrooms established via text messaging; providing online forums for the transmission of messages, comments and multimedia content among users; instant messenger service for shopping information service; electronic messaging services of smart phone applications; providing access to online community sites via smartphone applications; transmission of mobile content via a smart phone; providing access to online chat rooms and electronic bulletin boards; streaming of audio and video content over the internet and wireless networks; internet broadcasting services; broadcasting of audiovisual and multimedia content via the Internet; electronic bulletin board services that enable connection to a variety of thematic information and opinions via internet; provision of telecommunication access to viewing video of museums and exhibitions via telepresence robot; video conferencing services

29.

SAMYANG

      
Serial Number 79416576
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 30 - Basic staples, tea, coffee, baked goods and confectionery

Goods & Services

Flour mixes; crystallized rock sugar; maltose for food; wheat flour; biscuit mixes; mixes for the preparation of bread; sugar; potato starch for food; manioc starch for food; yuca starch for food; cassava starch for food; konjac starch for food; sweet potato starch for food; rice starch for food; arrowroot starch for food; glucose for food, namely, glucose for culinary purposes; fructose for food; liquid fructose for food; oligosaccharides for culinary purposes; glucose for culinary purposes; raw sugar; grain syrup, namely, brown rice syrup for flavoring food and beverages; palm sugar; beverages made of tea; natural sweeteners; coffee; cookie mixes; fructo-oligosaccharide for culinary purposes; food products for prevention of hangover consisting primarily of yeast, not for medical purposes; food products consisting primarily of yeast, not for medical purposes; food products against hangover consisting primarily of yeast, not for medical purposes; cube sugar; treacle; royal jelly for food purposes; natural sweeteners, in particular allulose for culinary purposes; sugar substitutes for culinary purposes.

30.

SAMYANG

      
Serial Number 79417631
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Development of computer software for data processing; research and development of vaccines and medicines; inspection of foodstuffs for quality control purposes; inspection of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research services; services for assessing the efficiency of pharmaceuticals; medical laboratories; medical research laboratory services; scientific research for medical purposes in the field of medicine; research of medicines; analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection, and research of medical products; consultancy in the field of testing, inspection, research of medical products; biopsy for medical research; blood testing for medical research purposes; blood collection for medical research purposes; engineer services in the field of medical technology; computer software development; cloud computing services, namely, cloud hosting provider services; technical research in the field of semiconductor manufacturing; research services relating to semiconductors; drug discovery services; development of pharmaceutical preparations and medicines

31.

SAMYANG

      
Serial Number 79417917
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for health care, namely, nutritional supplements; vaccines; food supplements; hangover remedies with vitamin B1 containing yeast-based ingredients for medical purposes; hangover remedies with vitamin B2 containing yeast-based ingredients for medical purposes; hangover remedies with vitamin C containing yeast-based ingredients for medical purposes; vitamin and mineral dietary supplements; veterinary substances and preparations, namely, veterinary vaccines; medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; filled syringes for medical purposes containing pharmaceuticals in the nature of anti-infectives; antibiotic ointments for pharmaceutical purposes; cachets for pharmaceutical purposes in the nature of pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations being hormone preparations for human use; pills for pharmaceutical purposes for the treatment of cancer and prevention of viruses; pills for pharmaceutical purposes, namely, pills for the treatment of infection and immune disorder; ferments for pharmaceutical purposes; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of respiratory diseases; pre-filled syringes for medical purposes sold filled with pharmaceuticals for skin care, skin regeneration, skin moisturization, aesthetic treatments, hyaluronic acids, Botulinum toxin and pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; skin anti-aging preparations for medical use; pharmaceuticals preparation, namely, phamaceutical fillers for medical use; pharmaceutical syringes prefilled with medical hyaluronic acid as the main ingredient; medicinal drinks; pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics, diuretics, and pharmaceutical preparations for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseases; medicinal infusions for treating dermatological, kidney, heart, urological, and circulatory diseases, as well as cancer and inflammatory conditions; pharmaceuticals, namely, antivirals; pharmaceuticals, namely, pharmaceuticals for the treatment of cancer; human vaccine preparations; medicines for human purposes for dental purposes; medicines for human purposes for the treatment of cardiovascular and cerebrovascular diseases; medicines for human purposes for the treatment of cancer; medicines for human purposes for the treatment and prevention of iron deficiency and anemia; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements; pharmaceutical preparations for wrinkle treatment; injectable pharmaceutical preparations for filling wrinkle in the form of gel; injectable dermal fillers; implantable medicines for the prevention and treatment of diabetes; implantable medicines for the prevention and treatment of cardiovascular diseases; implantable medicines for the prevention and treatment of central nervous system diseases; implantable medicines for the prevention and treatment of cancer; implantable medicines for the prevention and treatment of metabolism diseases; nutraceutical preparations for therapeutic or medical purposes; dermatological pharmaceutical products; gels, creams and solutions for dermatological use; pharmaceutical preparations for use in dermatology, namely, injectable dermatological fillers; pharmaceutical preparations for skin whitening; pharmaceutical preparations for skin moisturizing; injectable pharmaceutical preparations for skin moisturizing; pharmaceutical preparations for skin care; pharmaceutical preparations for skin regeneration; antibiotics; nicotine patches for use as aids to stop smoking; pharmaceutical preparations used in the smoking cessation, namely, smoking cessation preparations; anti-adhesion agents for medical purposes; surgical glues; denture adhesives; dental adhesives; medical adhesives for binding internal tissue; medical adhesives for binding wounds; hemostatics for medical purposes; transdermal patches for medical treatment; anti-cancer preparations.

32.

SAMYANG

      
Serial Number 79418274
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 29 - Meat, dairy products, prepared or preserved foods

Goods & Services

Processed food products against hangover mainly based on pueraria extract, not for medical purposes; processed food products against hangover mainly based on licorice extract, not for medical purposes; processed food products against hangover mainly based on fruit and vegetable extracts, not for medical purposes; frozen red ginseng for use as a vegetable; processed food products against hangover mainly based on yam extract, not for medical purposes; fermented processed red ginseng for use as a vegetable; processed food products against hangover mainly based on bean sprout extract, not for medical; processed food products against hangover mainly based on hovenia dulcis extract, not for medical purposes; processed red ginseng products, namely, preserved ginseng for use as a vegetable; red ginseng powders being processed vegetables; red ginseng jeolpyeon being sliced Korean red ginseng for use as a vegetable; red ginseng jelly for food purposes; processed oils and fats for food; vegetable oils and fats for food; perilla oil for food; peanut oil for food; corn oil for food; sesame oil for food; soya bean oil for food; sunflower oil for food; olive oil for food; canola oil for food.

33.

SAMYANG

      
Serial Number 79418453
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Unprocessed plastics for 3D printers; photocurable unprocessed artificial resins for 3D printers; unprocessed acrylic resins for 3D printers; unprocessed artificial resins for 3D printers; sensitized paper for photography; surfactants for industrial purposes; polymeric adsorbents; unprocessed plastics for industrial use; ultraviolet light-curable composite materials for engineering purposes; chemical additives for industrial purposes for photocurable unprocessed resins; photocurable unprocessed polymethyl methacrylate resins; meta acryl polymer; unprocessed plastics in all forms; photocurable unprocessed synthetic resins; photocurable resins, unprocessed; unprocessed synthetic resins; recalling agents using biomass for industrial purposes; chemical preparations in the nature of ion-exchange resins; chemical preparations in the nature of ion exchangers; polymerization plastics; catalysts for use in the manufacture of industrial chemicals; chemicals for use in the treatment of waste water; waste water treatment agents; unprocessed photocurable resin compositions containing polymers; unprocessed polyethtylene terephthalate resins; unprocessed polycarbonate resins; chemicals for use in the manufacture of plastics; chemical adsorbents for removing impurities from fuel; alcohol for industrial purposes; phenol for industrial purposes; flavonoids for industrial purposes; nitroaminophenol; nitrotoluene; nitrophenol; methyl alcohol (methanol) for industrial purposes; benzyl alcohol; bisphenol A; phenols; adhesives for industrial purposes; chemical additives for industrial purposes; photocatalysts; unprocessed polyurethane; unprocessed polyurethane resins; moistening agents; unprocessed silicone resins; water-softening preparations; emulsifiers for industrial purposes; metallic oxides for photoresist processes; photoresists; chemical thickening agents for use in the manufacture of cosmetic products.

34.

SAMYANG

      
Application Number 237848700
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations

Goods & Services

(1) Sheet masks for neck [cosmetics]; make-up; pores tightening mask packs used as cosmetics; cosmetic preparations for the hair and scalp; pre-moistened cleansing tissues; beauty creams; body and beauty care cosmetics; body creams; body cleanser; shampoos; sun block [cosmetics]; sunscreen preparations; toiletry preparations; skin lotions; cosmetic preparations for skin care; essential oils; facial cleansers; skin cleansing foams; hair care preparations; mask packs for cosmetic purposes; cotton wool and cotton tip sticks for cosmetic purposes; cosmetic facial masks; make-up removing preparations; tissues impregnated with cosmetics; cosmetics.

35.

SAMYANG

      
Application Number 238266500
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 41 - Education, entertainment, sporting and cultural services

Goods & Services

(1) Planning of entertainment performances; planning of performance events; educational services; arranging and conducting of seminars, conferences and exhibitions for cultural or educational purposes; organization of shows for cultural purposes; nursery school services; distance learning services provided on-line; distance learning services; kindergarten services; fitness and exercise club services.

36.

SAMYANG

      
Application Number 237848900
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 38 - Telecommunications services

Goods & Services

(1) Electronic transmission and streaming of digital media content for others via global and local computer networks; electronic exchange of messages via chat lines, chatrooms and Internet forums; transmission of data, audio, video and multimedia files; digital media streaming services; providing access to multimedia content on-line; transmission of messages and images; electronic messaging services; text messaging services; instant messaging services; wireless digital messaging services; telephone voice messaging services; virtual chatrooms established via text messaging; providing online forums for the transmission of messages, comments and multimedia content among users; instant messenger service for shopping information service; messaging services of smart phone applications; providing access to online community sites via smartphone applications; transmission of mobile content via a smart phone; providing access to online chat rooms and electronic bulletin boards; streaming of audio and video content over the internet and wireless networks; audio and video broadcasting services over the Internet; broadcasting of audiovisual and multimedia content via the Internet; electronic bulletin board services that enable connection to a variety of thematic information and opinions via internet; provision of telecommunication access to viewing video of museums and exhibitions via telepresence robot; videoconferencing services.

37.

SAMYANG

      
Application Number 238266400
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Development of computer software for data processing; research and development of vaccines and medicines; inspection of foodstuffs for quality control; inspection of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research services; services for assessing the efficiency of pharmaceuticals; medical laboratories; medical research laboratory services; scientific research for medical purposes; medicine research; analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection, and research of medical products; consultancy in the field of testing, inspection, research of medical products; biopsy for medical research; blood testing for medical research; blood collection for medical research; engineer services in the field of medical technology; computer software development; cloud computing services; technical research in the field of semiconductor manufacturing; research services relating to semiconductors; drug discovery services; development of pharmaceutical preparations and medicines.

38.

SAMYANG

      
Serial Number 79416319
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 39 - Transport, packaging, storage and travel services

Goods & Services

Delivery services, namely, delivery of goods; storage of goods; transport, delivery, packaging, and storage of goods; transportation of goods; wrapping of goods; transport, delivery, packaging, and storage of food and beverages; locating and tracking of people for transportation purposes; providing transportation information; warehousing services; supply chain logistics and reverse logistics services consisting of the storage, transportation and delivery of goods for others by air, rail, ship or truck

39.

SAMYANG

      
Serial Number 79417630
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer software for use in customer relationship management (CRM); downloadable software for commerce over a global communications network; software as a Medical Device (SaMD), downloadable, for use as electrocardiographs; software as a Medical Device (SaMD), downloadable, for analyzing heart rate data; downloadable Software as a Medical Device (SaMD) for wireless remote control of and synchronization of X-Ray machines; downloadable Software as a Medical Device (SaMD) for wireless remote control of and synchronization of computed tomography (CT) apparatus; downloadable Software as a Medical Device (SaMD) for displaying diagnostic tests; downloadable instant messaging software; downloadable computer software for use as a digital wallet; downloadable interactive multimedia computer program for providing medical information; downloadable interactive multimedia computer program for engineering research; downloadable interactive multimedia computer program for medical research; downloadable computer software for data processing; downloadable computer software for database management; downloadable computer software for managing and verifying financial transactions; downloadable computer software for enterprise resource planning (ERP); downloadable computer software to maintain and operate computer systems; downloadable computer e-commerce software to allow users to perform electronic business transactions via a global computer network; protective helmets; foldable protective helmets; crash helmets

40.

SAMYANG

      
Serial Number 79418194
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 41 - Education, entertainment, sporting and cultural services

Goods & Services

Planning of entertainment performances; planning of performance events; educational services in the field of vocational traning; educational services in the fields of chemistry, biology, engineering, medical science, food science, nutritional science, information technology, and cosmetology; arranging and conducting of seminars, conferences and exhibitions for cultural or educational purposes; organization of shows for cultural purposes; nursery school services; distance learning services provided on-line at the primary, secondary and university level; distance learning services provided on-line in the field of vacational training; distance learning services, namely, conducting distance learning instruction at the primary, secondary, college, and university level; distance learning services, namely, conducting distance learning instruction in the field of vacational training; kindergarten services, namely, educational services in the nature of providing instruction at the kindergarten level; fitness and exercise club services

41.

SAMYANG

      
Serial Number 79418985
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 35 - Advertising and business services

Goods & Services

Retail store services featuring unprocessed artificial resins for 3D printers; business assistance, management and information services; retail store services featuring surfactants for industrial purposes; business advice and information relating to customer relationship management (CRM); retail store services featuring downloadable computer software for use in customer relationship management (CRM); customer relationship management; retail store services featuring fruit juices; advertising and marketing; retail store services featuring photocurable resins, unprocessed; retail store services featuring wheat flour; retail store services featuring biscuit mixes; retail store services featuring hangover remedies with vitamin C containing yeast-based ingredients for medical purposes; organisation of exhibitions and events for commercial or advertising purposes; promoting the goods and services of others; provision of an online marketplace for buyers and sellers of goods and services; retail store services featuring reverse osmosis membrane filters for water treatment; retail store services featuring non-alcoholic beverages for prevention of hangover, not for medical purposes; retail store services featuring functional beverages against hangover, not for medical purposes; retail store services featuring potato starch for food; retail store services featuring manioc starch for food; retail store services featuring yuca starch for food; retail store services featuring cassava starch for food; retail store services featuring konjac starch for food; retail store services featuring sweet potato starch for food; retail store services featuring rice starch for food; retail store services featuring arrowroot starch for food; retail store services featuring drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; retail store services featuring oligosaccharides for culinary purposes; retail store services featuring medical apparatus and instruments for treating cardiovascular disease; retail store services featuring medical apparatus and instruments relating to neurovegetative reactivity; retail store services featuring medical apparatus and instruments for use in surgery; retail store services featuring medical apparatus and instruments for diagnostic radiopharmaceutical use; retail store services featuring medical apparatus and instruments for treating osteoarthritis and osteoporosis; retail store services featuring medical apparatus and instruments for monitoring blood properties and respiratory events; retail store services featuring pharmaceuticals preparation, namely, phamaceutical fillers for medical use; retail store services featuring medical apparatus for injecting fillers, namely, medical filler syringes sold empty; retail store services featuring medicinal drinks; retail store services featuring pharmaceuticals, namely, antivirals; retail store services featuring pharmaceuticals, namely, pharmaceuticals for the treatment of cancer; retail store services featuring chemical preparations in the nature of ion-exchange resins; retail store services featuring chemical preparations in the nature of ion exchangers; retail store services featuring downloadable computer software for enterprise resource planning (ERP); arranging of contracts for the purchase and sale of goods and services, for others; retail store services featuring beverages made of tea; retail store services featuring coffee; retail store services featuring unprocessed polyethtylene terephthalate resins; retail store services featuring processed food products against hangover mainly based on hovenia dulcis extract, not for medical purposes; retail store services featuring processed red ginseng products, namely, preserved ginseng for use as a vegetable; retail store services featuring cosmetics; retail store services featuring food products against hangover consisting primarily of yeast, not for medical purposes

42.

SAMYANG

      
Serial Number 79419398
Status Pending
Filing Date 2024-12-18
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Medical apparatus for injecting fillers, namely, medical syringes for plastic surgery; surgical apparatus and instruments for veterinary use; liquid medicine syringes, sold empty; devices for injecting pharmaceuticals; surgical instruments and apparatus; surgical apparatus and instruments for medical, dental or veterinary use; medical instruments for percutaneous tracheostomy; medical instruments for cutting tissue; medical instruments for recording heart activity; medical devices, namely, external fixators; medical instruments namely, external fixators; medical instruments, namely, orthopedic apparatus and instruments; medical instruments for use in performing biopsies; medical instruments for analysing and identifying bacteria; medical instruments for cardiovascular diagnostics; medical instruments, namely, biosensors for detecting infectious diseases; medical apparatus and instruments other than for dental purposes, namely, x-ray CT scanners; medical apparatus and instruments other than for dental purposes, namely, medical apparatus and instruments for monitoring pregnancy status; medical apparatus and instruments other than for dental purposes, namely, medical apparatus for removing sebum from pores; medical apparatus and instruments for treating cardiovascular disease; medical apparatus and instruments relating to neurovegetative reactivity; medical apparatus and instruments for use in surgery; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for treating osteoarthritis and osteoporosis; medical apparatus and instruments for monitoring blood properties and respiratory events; surgical apparatus and instruments for medical use; jet injectors for medical use; syringes for medical purposes and for injections; diagnostic apparatus for medical purposes, namely, medical diagnostic apparatus for testing for viruses; diagnostic apparatus for medical purposes, namely, ultrasound diagnostic apparatus, X-ray diagnostic apparatus and diagnostic apparatus for the detection of cancer; diagnostic apparatus for medical purposes, namely, apparatus for use in blood analysis; diagnostic apparatus for medical purposes, namely, for testing blood sugar levels, cancer cells, DNA, RNA; medical apparatus for injecting fillers, namely, medical filler syringes sold empty; syringes for injections; medical apparatus and instruments for administering pharmaceuticals, namely, for monitoring patient medication; injection needles; skin stimulation apparatus for therapeutic purposes; dermatological apparatus for injecting fillers; skin regeneration therapy apparatus; medical apparatus for skin wrinkle removal; medical apparatus and instruments for the treatment of skin; sutures; medical apparatus for tissue adhesives for use in surgery; surgical mesh comprised primarily of artificial materials; medical apparatus for preventing adhesion; thread for medical use

43.

ORAL COMPOSITION OF PALBOCICLIB

      
Application Number KR2024007097
Publication Number 2024/242504
Status In Force
Filing Date 2024-05-24
Publication Date 2024-11-28
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lim, Hye Jung
  • Kim, Nam Hyuck
  • Park, Sang Yeob

Abstract

The present invention relates to an oral composition of palbociclib or a pharmaceutically acceptable salt thereof useful for the treatment of advanced or metastatic breast cancer.

IPC Classes  ?

  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
  • A61P 35/00 - Antineoplastic agents
  • A61K 9/00 - Medicinal preparations characterised by special physical form

44.

KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS

      
Application Number 18288677
Status Pending
Filing Date 2022-04-29
First Publication Date 2024-11-07
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Kim, Go Eun
  • Park, Joon Young

Abstract

The present invention relates to a kit for preparing nanoparticles containing a drug and, more specifically, to a kit for preparing drug-containing nanoparticles, the kit enabling a drug to be easily contained in nanoparticles by simple mixing only, preferably, in a specific weight ratio, the drug and nanoparticles containing a cationic compound and a polylactate, as kit constituent components comprising no amphiphilic polymers, and being designed to enable the efficiency of drug delivery into cells to be greater than that of a kit comprising an amphiphilic polymer.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
  • A61K 35/76 - VirusesSubviral particlesBacteriophages
  • A61K 38/00 - Medicinal preparations containing peptides

45.

COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES NOT CONTAINING AMPHIPHILIC POLYMER

      
Application Number 18288722
Status Pending
Filing Date 2022-04-29
First Publication Date 2024-11-07
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Kim, Go Eun
  • Park, Joon Young

Abstract

The present invention relates to a composition forming nanoparticles for delivering a drug, and more specifically, to a composition for drug delivery comprising nanoparticles containing cationic compounds and a polylactic acid salt but not containing an amphiphilic polymer, wherein a drug can easily be incorporated into the nanoparticles by simply mixing the drug therewith, and furthermore, cell delivery efficiency of the drug can be further increased compared to nanoparticles containing an amphiphilic polymer.

IPC Classes  ?

  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • A61K 9/51 - Nanocapsules

46.

NanoReady

      
Application Number 1804500
Status Registered
Filing Date 2024-06-07
Registration Date 2024-06-07
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Pharmaceutical preparations for health care; medicine cases, portable, filled; vaccines; food supplements; vitamin and mineral dietary supplements; veterinary substances and preparations; medicinal preparations for the mouth in the form of drops, capsules, tablets or compressed tablets; ointments for pharmaceutical purposes; cachets for pharmaceutical purposes; pharmaceutical preparations being hormone preparations for human use; ferments for pharmaceutical purposes; pre-moistened medicated tissues; elixirs [pharmaceutical preparations]; drugs for medical purposes; pharmaceutical drugs; human vaccine preparations; medicines for human purposes; pharmaceutical preparations; nutraceutical preparations for therapeutic or medical purposes; antibiotics; drug delivery agents; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements. Surgical gloves; surgical apparatus and instruments for veterinary use; veterinary apparatus; surgical instruments; surgical sutures; surgical apparatus and instruments for medical, dental or veterinary use; medical instruments; medical apparatus and instruments; sanitary masks for medical use; cold-hot massage apparatus for medical use; suture materials for medical use; surgical apparatus and instruments for medical use; thread for medical use; protective face masks for medical use; gloves for medical purposes; medical apparatus; apparatus for drug administration; syringes for injection of medical substances; orthopedic articles; dental instruments. Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; preservation of pharmaceuticals; custom manufacture of pharmaceuticals; destruction of medical waste; custom manufacture of medical devices for others; custom assembling of electronic components for medical devices; recycling of medical waste; processing of pharmaceuticals; manufacture of custom dental bridges for others; custom manufacture of dental prosthesis and dentures; processing and treatment of chemical reagents. Research and development of vaccines and medicines; biological information check (genetic testing for medical research purposes); pharmaceutical research services; inspection of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; services for assessing the efficiency of pharmaceuticals; technological and scientific remote monitoring services relating to medical diagnostic devices (remote monitoring of medical diagnostic systems); medical laboratories; providing computer software technical support services in the field of medical diagnostics; providing technological support services regarding medical diagnostic instruments; research of medicines; analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection and research of medical products; consultancy in the field of testing, inspection, research of medical products; blood testing for medical research; blood collection for medical research; biopsy for medical research; engineering services in the field of medical technology.

47.

POWDER FORMULATION FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR, COMPRISING SAME

      
Application Number 18580885
Status Pending
Filing Date 2022-07-21
First Publication Date 2024-08-08
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Ji Hoon
  • Yoon, Hye Sung
  • Lim, Soo Mee

Abstract

The present invention relates to a powder formulation for tissue repair, a preparation method therefor, and an injectable composition for tissue repair, comprising same, and, more specifically, to: a powder formulation, a preparation method therefor, and an injectable composition for tissue repair, comprising same, the powder formulation comprising a biocompatible copolymer, which is a copolymer of a hydrophobic biocompatible polymer and a hydrophilic biocompatible polymer and forms, in an aqueous medium, micelle-type nanoparticles with an average diameter of a specific range and/or has a ratio, of a specific level or less, of the hydrophilic biocompatible polymer to the hydrophobic biocompatible polymer, being in a powder form so as to facilitate transport, storage and handling, being readily dissolved in an aqueous medium at room temperature so as to form stable nanoparticles, and allowing collagen induction to be performed without being phagocytosed by macrophages after being introduced into the body, thereby exhibiting an excellent tissue repair effect.

IPC Classes  ?

  • A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages

48.

Medical thread

      
Application Number 35516432
Grant Number D1038394
Status In Force
Filing Date 2021-12-10
First Publication Date 2024-08-06
Grant Date 2024-08-06
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Jung, Jaehoon
  • Choi, Hwanseok

49.

PHARMACEUTICAL COMPOSITION OF FULVESTRANT WITH EXCELLENT PHARMACOKINETIC PROPERTIES AND PREPARATION METHOD THEREFOR

      
Application Number KR2023021820
Publication Number 2024/144298
Status In Force
Filing Date 2023-12-28
Publication Date 2024-07-04
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, Jae Young
  • Park, Sang Yeob
  • Cho, Joong Woong

Abstract

The present invention relates to a pharmaceutical composition containing fulvestrant and a preparation method therefor and, more specifically, to a pharmaceutical composition and a preparation method therefor wherein the pharmaceutical composition comprises a combination of the insoluble drug fulvestrant with a nonionic surfactant, castor oil, and a specific alcohol and does not contain lecithin or contains lecithin in a specific amount below a certain content, thereby exhibiting an excellent pharmacokinetic profile and equivalent pharmacological therapeutic effects compared to existing fulvestrant formulations.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61K 31/565 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
  • A61P 35/00 - Antineoplastic agents

50.

MULTIPLE-RELEASE-CONTROLLED TABLET COMPOSITION OF RUXOLITINIB, AND PREPARATION METHOD THEREFOR

      
Application Number KR2023021739
Publication Number 2024/144258
Status In Force
Filing Date 2023-12-27
Publication Date 2024-07-04
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Kim, Nam Hyuck
  • Park, Sang Yeob

Abstract

The present invention relates to a multiple-release-controlled tablet composition of ruxolitinib or a pharmaceutically acceptable salt thereof, the composition being effective in the treatment of Janus kinase-associated diseases such as myeloproliferative disorder, and a preparation method therefor, and, more specifically, to a multiple-release-controlled tablet composition and a preparation method therefor, the composition controlling the release rate of a drug so as to effectively maintain the drug at an effective blood concentration or higher in vivo while exhibiting the highest drug blood concentration similar to those of commercially available immediate-release formulations, thereby enabling once-daily administration unlike commercial formulations, which are administered twice daily.

IPC Classes  ?

  • A61K 9/24 - Layered or laminated unitary dosage forms
  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
  • A61P 7/00 - Drugs for disorders of the blood or the extracellular fluid
  • A61P 43/00 - Drugs for specific purposes, not provided for in groups

51.

DRY FORMULATION FOR TISSUE REPAIR

      
Application Number KR2023021287
Publication Number 2024/136537
Status In Force
Filing Date 2023-12-21
Publication Date 2024-06-27
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, Jong Pil
  • Park, Na Jeong
  • Park, Ji Hoon
  • Yoon, Hye Sung

Abstract

The present invention relates to a dry formulation for tissue repair and, specifically, to a dry formulation for tissue repair, comprising a copolymer of a hydrophilic biocompatible polymer and a hydrophobic biocompatible polymer, and an additive, wherein the formulation exhibits excellent tissue repair effects upon injection into the human body after reconstruction in an aqueous medium.

IPC Classes  ?

  • A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • A61L 27/50 - Materials characterised by their function or physical properties

52.

AQUEOUS GEMCITABINE SOLUTION PREPARATION FOR ROOM-TEMPERATURE STORAGE WITH IMPROVED STABILITY AND PREPARATION METHOD THEREFOR

      
Application Number KR2023019853
Publication Number 2024/123029
Status In Force
Filing Date 2023-12-05
Publication Date 2024-06-13
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Kim, Gyeong Hae
  • Cho, Joong Woong

Abstract

The present invention relates to an aqueous gemcitabine solution preparation and a preparation method therefor, the aqueous gemcitabine solution preparation comprising, as an active ingredient, gemcitabine or a pharmaceutically acceptable salt thereof and being capable of being stored and transported at room temperature due to having very excellent stability, thus being easier to handle than existing products that require refrigeration conditions.

IPC Classes  ?

  • A61K 9/08 - Solutions
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61K 47/02 - Inorganic compounds
  • A61K 31/7068 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
  • A61P 35/00 - Antineoplastic agents

53.

NANOREADY

      
Serial Number 79402228
Status Pending
Filing Date 2024-06-07
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Pharmaceutical preparations for health care, in particular for the prevention and treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases and for use in genetic therapy for the prevention and treatment of genetic disorders; medicine cases, portable, filled, in the nature of first-aid kits; vaccines; food supplements; vitamin and mineral dietary supplements; veterinary substances and preparations for the prevention and treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases and for use in genetic therapy for the prevention and treatment of genetic disorders; medicinal preparations for the mouth in the form of drops, capsules, tablets, or compressed tablets for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; ointments for pharmaceutical purposes for the treatment of pain, inflammation and skin disorders; cachets for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; pharmaceutical preparations being adrenal, parathyroid, pituitary, pancreas, and salivary gland hormone preparations for human use; ferments for pharmaceutical purposes; pre-moistened medicated tissues; pharmaceutical preparations, namely, elixirs for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; pharmaceutical drugs, namely, pharmaceutical preparations for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; human vaccine preparations; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; pharmaceutical preparations for the treatment of cancer; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; antibiotics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules sold empty and tablets that provide controlled release of the active ingredients that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; preservation of pharmaceuticals; custom manufacture of pharmaceuticals; destruction of medical waste; custom manufacture of medical devices for others; custom assembling of electronic components for medical devices; recycling of medical waste; processing of pharmaceuticals being custom manufacture of pharmaceuticals; manufacture of custom dental bridges for others; custom manufacture of dental prosthesis and dentures; processing and treatment of chemical reagents Surgical gloves; surgical apparatus and instruments for veterinary use; veterinary apparatus, namely, electrocardiographs, X-ray apparatus, ultrasound apparatus and medical imaging apparatus for veterinary purposes; surgical instruments for use in general surgery; surgical sutures; surgical apparatus and instruments for medical, dental or veterinary use; medical instruments for use in general surgery; medical apparatus, namely medical radiation apparatus, medical X-ray apparatus, and medical imaging apparatus; medical instruments, namely medical hearing instruments; sanitary masks for medical use; cold-hot massage apparatus for medical use; suture materials for medical use; surgical apparatus and instruments for medical use; thread for medical use; protective face masks for medical use; gloves for medical purposes; medical apparatus, namely, medical apparatus for detecting cancer, medical imaging apparatus, ultrasonic medical diagnostic apparatus; apparatus for drug administration, namely, infusion and injection devices for administering drugs; syringes for injection of medical substances; orthopedic articles, namely, orthopedic belts, orthopedic soles, orthopedic footwear, orthopedic bandages, orthopedic bandages for joints and orthopaedic hosiery, and orthopedic apparatus and instruments for diagnostic and therapeutic use; dental instruments, namely root canal therapy instruments used to shave the inside of a root canal, dental root files used in root canal therapy procedures, reusable and recyclable prophy angles, prophy angles, disposable prophy angles, oral irrigators, hemostats that clamp blood vessels to diminish or halt blood flow, crown and bridge removers Research and development of vaccines and medicines; biological information check, namely, genetic testing for medical research purposes; pharmaceutical research services; inspection of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; services for assessing the efficiency of pharmaceuticals, namely, product quality testing services; technological and scientific remote monitoring services relating to medical diagnostic devices, namely, remote monitoring of medical diagnostic systems for quality control purposes; medical research laboratories; providing computer software technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; providing technological support services regarding medical diagnostic instruments, namely, troubleshooting of computer software problems; scientific research relating to medicines; analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection and scientific research of medical products; consultancy in the field of testing, inspection, and scientific research of medical products; blood testing for scientific medical research purposes; engineering services in the field of medical technology

54.

POWDER FORMULATION FOR TISSUE REPAIR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR COMPRISING SAME

      
Application Number KR2023018442
Publication Number 2024/106970
Status In Force
Filing Date 2023-11-16
Publication Date 2024-05-23
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Ji Hoon
  • Ko, Suk Yen
  • Park, Na Jeong
  • Yoon, Hye Sung
  • Lee, Jong Pil

Abstract

The present invention relates to a powder formulation for tissue repair and an injectable composition for tissue repair comprising same and, more particularly, to: a powder formulation comprising a copolymer of a hydrophilic biocompatible polymer and a hydrophobic biocompatible polymer, wherein when a reference solution comprising the powder formulation at a specific concentration is diluted according to a series of increasing dilution factors, the number of polymer particles in the diluted solution is greater than or equal to the number of polymer particles in the reference solution at a particular dilution factor interval, and then exhibits a decreasing behavior as the dilution factors increase; and a tissue repair injectable composition comprising same.

IPC Classes  ?

  • A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • A61L 27/58 - Materials at least partially resorbable by the body
  • C08L 71/02 - Polyalkylene oxides
  • C08L 67/04 - Polyesters derived from hydroxy carboxylic acids, e.g. lactones

55.

CATIONIC LIPIDS AND METHOD FOR PREPARING SAME

      
Application Number KR2023013708
Publication Number 2024/106715
Status In Force
Filing Date 2023-09-13
Publication Date 2024-05-23
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Jong Min
  • Lee, So Jin
  • Seong, Shi Hwa
  • Kyung, Kyu Jin
  • Kim, Sol
  • Nam, Joung Pyo
  • Yoon, Yoo Jeong

Abstract

The present invention relates to cationic lipids and a method for preparing same, more specifically to cationic lipids that facilitate forming a complex with anionic medicinal material to thus be useful for drug delivery, and to a method for preparing the cationic lipids.

IPC Classes  ?

  • C07C 219/18 - Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
  • C07C 213/02 - Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
  • C07C 213/08 - Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups

56.

NANOPARTICLE COMPOSITION FOR DRUG DELIVERY

      
Application Number KR2023016417
Publication Number 2024/106780
Status In Force
Filing Date 2023-10-20
Publication Date 2024-05-23
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Yoo, Seung Ju
  • Lee, So Jin
  • Nam, Joung Pyo
  • Park, Jong Min
  • Seong, Shi Hwa
  • Jeong, Seung Wei
  • Han, Ji Hye

Abstract

The present invention relates to a nanoparticle composition for drug delivery and, more specifically, to a composition for drug delivery, wherein the composition comprises an amphiphilic block copolymer and a lipid with a specific structure that can easily form complexes with anionic drugs, whereby the composition can easily form drug-containing nanoparticles and thus is useful for drug delivery, especially for targeted delivery of drugs to the lungs.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy

57.

CATIONIC LIPIDS AND MANUFACTURING METHOD THEREFOR

      
Application Number KR2023013008
Publication Number 2024/101618
Status In Force
Filing Date 2023-08-31
Publication Date 2024-05-16
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Jong Min
  • Lee, So Jin
  • Seong, Shi Hwa
  • Kyung, Kyu Jin
  • Kim, Sol
  • Nam, Joung Pyo
  • Yoon, Yoo Jeong

Abstract

The present invention relates to cationic lipids and a manufacturing method therefor. More specifically, the present invention is concerned with cationic lipids that can easily form complexes with anionic drugs and thus are useful for drug delivery, and a method for manufacturing same.

IPC Classes  ?

  • C07C 219/18 - Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
  • C07C 213/02 - Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
  • C07C 213/08 - Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups

58.

LIPID HAVING AMIDE AND ESTER FUNCTIONAL GROUPS, AND METHOD FOR PRODUCING SAME

      
Application Number KR2023016408
Publication Number 2024/096408
Status In Force
Filing Date 2023-10-20
Publication Date 2024-05-10
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Jong Min
  • Seong, Shi Hwa
  • Kyung, Kyu Jin
  • Yoo, Seung Ju
  • Yoon, Yoo Jeong
  • Lee, So Jin
  • Han, Ji Hye
  • Kim, Bong Oh
  • Nam, Joung Pyo

Abstract

The present invention pertains to a lipid having amide and ester functional groups, and a method for producing same. More specifically, the present invention pertains to: an ionized lipid that forms a polyplex with an anionic drug and is useful for drug delivery due to a specific structure having amide and ester functional groups; and a method for producing same.

IPC Classes  ?

  • C07C 237/06 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
  • C07C 231/14 - Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups

59.

Medical thread

      
Application Number 35516429
Grant Number D1018847
Status In Force
Filing Date 2021-12-10
First Publication Date 2024-03-19
Grant Date 2024-03-19
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Kim, Geonwoo
  • Ryu, Daehui

60.

KIT FOR MANUFACTURE OF DRUG-CONTAINING NANOPARTICLES AND NANOPARTICLE COMPOSITION FOR DRUG DELIVERY

      
Application Number KR2023010824
Publication Number 2024/053862
Status In Force
Filing Date 2023-07-26
Publication Date 2024-03-14
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Kim, Go Eun
  • Kyung, Kyu Jin
  • Kim, So Young
  • Nam, Joung Pyo
  • Lee, So Jin
  • Park, Jong Min
  • Seo, Won Il

Abstract

The present invention relates to a kit for construction of drug-containing nanoparticles and a nanoparticle composition for drug delivery. More specifically, the present invention concerns a kit for construction of drug-containing nanoparticles and a nanoparticle composition for drug delivery, each designed to increase the efficiency of cellular drug delivery by utilizing nanoparticles that include a cationic compound and an anionic polymer compound with at least one acidic functional group.

IPC Classes  ?

61.

LAFULLEN

      
Application Number 1773828
Status Registered
Filing Date 2023-11-07
Registration Date 2023-11-07
Owner Samyang Holdings Corporation (Republic of Korea)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Pre-filled syringes for medical purposes; skin anti-aging preparation for medical purposes; fillers for medical purposes; pharmaceutical syringes pre-filled with hyaluronic acid for medical use as the main ingredient; medicinal infusions; pharmaceuticals; medicines for human purposes; medicines for the treatment of wrinkle; injectable pharmaceutical preparation to fill wrinkle in the form of gels; injectable dermal fillers; injectable medicinal solutions; pharmaceutical preparations for use in dermatology; solutions for dermatological use; dermal fillers for use in dermatology; pharmaceutical preparation for skin care for whitening; pharmaceutical preparation for skin care for moisturizing; injectable pharmaceutical preparation for skin care for moisturizing; pharmaceutical preparation for skin care; pharmaceutical preparation for regeneration of skin. Suture apparatus; suture needles; sutures; suture materials; annuloplasty rings; medical apparatus and instruments for cosmetic surgery; suturing instruments; surgical thread for body insertion; surgical drapes; surgical sutures; thread, surgical; medical drapes; lifting thread for medical purposes; medical devices for suturing; thread inserter for medical use; thread for medical use; support bandages for medical purposes; instruments for use in skin plastic surgery for medical purposes; orthopedic articles; support bandages; syringes for injection of fillers for cosmetic surgery; syringes for liquid medicine; devices for injecting pharmaceuticals; medical apparatus and instruments, not for dental purposes; medical apparatus and instruments; injectors for medical purposes; injection syringes for medical use; diagnostic apparatus for medical purposes; medical apparatus for injecting fillers; syringes for injection of fillers for medical use; syringes for injection of medical substances; medical apparatus and instruments for administering pharmaceuticals; injection needles for medical use; syringes for injections; medication injectors; syringes for injection of fillers for dermatological use; medical devices for skin irritation therapy; skin regeneration therapy apparatus; medical apparatus for skin wrinkle removal; medical apparatus and instruments for the treatment of skin.

62.

SAMYANG

      
Application Number 1753850
Status Registered
Filing Date 2023-07-31
Registration Date 2023-07-31
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 19 - Non-metallic building materials
  • 30 - Basic staples, tea, coffee, baked goods and confectionery

Goods & Services

Unprocessed polycarbonate resins; unprocessed polyester resins; unprocessed polyethylene resins; cellulose acetate, unprocessed; unprocessed polyvinyl chloride resins; chemical pulp; unprocessed nylon resins; unprocessed phenolic resins; unprocessed polybutylene terephthalate resins; polyester elastomer resins; unprocessed polyethtylene terephthalate resins; unprocessed polypropylene resins; unprocessed plastics for industrial use; unprocessed plastics in all forms; unprocessed artificial resins; unprocessed plastics; unprocessed synthetic resins; unprocessed plastic in the form of powder or granules; unprocessed cellulose plastic resins; polymerization plastics; nitrogen compounds; ion exchangers (chemical preparations); chemical adsorbents for removing impurities from fuel; oxidizing agents; rubber cement for repairing pneumatic tires; artificial sweeteners for industrial purposes; oxides; bentonite; antifreeze; preparations of microorganisms, other than for medical and veterinary use; birdlime; test paper (other than for medical or veterinary purposes); hydraulic oils; metalloids; compositions for the manufacture of technical ceramics. Hemostatics for medical purposes; gauze for medical purposes; vulnerary sponges; cotton for medical purposes; sticking plasters for medical use; medical dressings; adhesive dressings for medical purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; pharmaceutical preparations for chemical disorder treatment; pharmaceutical drugs; drugs for medical purposes; pharmaceutical preparations for health care; nutraceutical preparations for therapeutic or medical purposes; hormone preparations for pharmaceutical use; ferments for pharmaceutical purposes; ointments for pharmaceutical purposes; cachets for pharmaceutical purposes; veterinary substances and preparations; pharmaceutical preparations; human vaccine preparations; vaccines; antibiotics; medicinal preparations for the mouth in the form of drops, capsules, tablets or compressed tablets; food supplements; vitamin and mineral dietary supplements; pre-moistened medicated tissues; medicine cases, portable, filled; diapers for medical purposes; dietetic food supplements; preparations of microorganisms for medical or veterinary use; medicines for human purposes; teeth filling material; fly glue; adhesive plasters; medicated plasters; pharmaceutical preparations for use in discouraging the smoking habit. Medical instruments; medical apparatus and instruments; surgical apparatus and instruments for medical use; medical apparatus; surgical apparatus and instruments for medical, dental or veterinary use; apparatus for drug administration; syringes for injection of medical substances; surgical instruments; cold and hot massage apparatus for medical purposes; veterinary apparatus; surgical apparatus and instruments for veterinary use; orthopedic articles; thread for medical use; suture materials; sutures; dental instruments; reusable sanitary masks for protection against viral infection; protective face masks for medical use; gloves for medical purposes; injection needles for medical use; scalpels; support bandages; sterilized cloth for medical purposes; sterilized cloth containing anesthetic for medical purposes; lamps for medical purposes; elastic tubular bandages for supporting limbs; compression bandages; lighting for medical use; electric scalpels for surgical purposes. Manufactured timber; non-metallic minerals for building or construction, as far as unprocessed; building glass; structures, namely, aquaria; tiles and paving slabs, not of metal; non-luminous and non-mechanical signs, not of metal; advertisement columns, not of metal; monuments, not of metal; diving boards, not of metal; rocket launching platforms, not of metal; insect screens, not of metal; non-metal artificial fish reefs; prefabricated non-metal buildings; pre-fabricated non-metal pigsties; non-metal railroad ties; tiles, not of metal; works of art of stonemasonry; building stone; storage tanks of masonry; statues of stone, concrete or marble; building materials, namely, manufactured cement; asphalt, pitch and bitumen; agglomerated cork for building; outdoor blinds, not of metal and not of textile; monuments of concrete; tar; paint spraying booths, not of metal; building materials made of synthetic elements. Sugar; natural sweeteners; sugar substitutes for culinary purposes; fructose for food; glucose for food; glucose for culinary purposes; fructo-oligosaccharide for culinary purposes; liquid fructose; honey; maltose; oligosaccharides for culinary purposes; cube sugar; starch syrup for food; powdered starch syrup for food; grain syrup; rice grain syrup; maple syrup; spices; food flavorings, other than essential oils; ice.

63.

COMPOSITION FOR HYDROGEL FORMATION, HYDROGEL FORMED BY PHOTO-CROSSLINKING SAME, AND METHOD FOR PREPARING HYDROGEL

      
Application Number 18019751
Status Pending
Filing Date 2021-08-05
First Publication Date 2023-09-21
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Chang, Ji Hyun
  • Kim, Hyung Hwan
  • Yoon, Hye Sung

Abstract

The present invention relates to a composition for hydrogel formation, a hydrogel formed by photo-crosslinking same, and a method for preparing the hydrogel and, more specifically, to a composition which comprises a photo-initiator and a polyglutamic acid polymer having a photo-crosslinkable functional group introduced thereto and is capable of forming a hydrogel in real time through photo-crosslinking, to a hydrogel which is formed by photo-crosslinking the composition and can be utilized as a tissue adhesive, a surgical sealant, anti-adhesive agent, or the like due to excellent biocompatibility, superior adhesive strength in wet environments, flexibility, and ease of use, and to a method for preparing the hydrogel.

IPC Classes  ?

  • C08L 77/04 - Polyamides derived from alpha-amino carboxylic acids
  • C08J 3/24 - Crosslinking, e.g. vulcanising, of macromolecules
  • C08J 3/075 - Macromolecular gels
  • C08J 3/28 - Treatment by wave energy or particle radiation
  • A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
  • A61L 24/06 - Surgical adhesives or cementsAdhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds

64.

SAMYANG

      
Serial Number 79380095
Status Pending
Filing Date 2023-07-31
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 19 - Non-metallic building materials
  • 30 - Basic staples, tea, coffee, baked goods and confectionery

Goods & Services

Unprocessed polycarbonate resins; unprocessed polyester resins; unprocessed polyethylene resins; acetate of cellulose, unprocessed; unprocessed polyvinyl chloride resins; chemical pulp; unprocessed nylon resins; unprocessed phenolic resins; unprocessed polybutylene terephthalate resins; unprocessed polyester elastomer resins; unprocessed polyethtylene terephthalate resins; unprocessed polypropylene resins; unprocessed plastics for industrial use; unprocessed plastics in all forms; unprocessed artificial resins; unprocessed plastics; unprocessed synthetic resins; unprocessed plastic in the form of powder or granules; unprocessed cellulose plastic resins; polymerization plastics; nitrogen compounds; ion exchangers, namely, Chemical preparations in the nature of ion-exchange resins; chemical adsorbents for removing impurities from fuel; oxidizing agents; rubber cement for repairing pneumatic tires; artificial sweeteners for industrial purposes; oxides; bentonite; anti-freeze; preparations of microorganisms, other than for medical and veterinary use; birdlime, namely, lime acetate; chemical test paper other than for medical or veterinary purposes; hydraulic oils; metalloids, namely, metal chlorides; chemical compositions for the manufacture of technical ceramics Styptic preparations; medical hemostatic paste; gauze for medical purposes; vulnerary sponges; cotton for medical purposes; sticking plasters for medical use; medical dressings; adhesive dressings for medical purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; pharmaceutical preparations for chemical disorder treatment; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for health care, namely, nutritional supplements; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes; hormone preparations being pharmaceuticals in the nature of hormones for medical purposes; ferments for pharmaceutical purposes; antibiotic ointments for pharmaceutical purposes; cachets for pharmaceutical purposes in the nature of pharmaceutical preparations for treating respiratory diseases; veterinary substances and preparations, namely, veterinary vaccines; pharmaceutical preparations for the treatment and prevention of cancer; human vaccine preparations; vaccines; antibiotics; medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; food supplements; vitamin and mineral dietary supplements; pre-moistened medicated tissues; medicine cases, portable, filled, namely, first aid kits; adult diapers for medical purposes; dietary food supplements; preparations of microorganisms for medical or veterinary purposes; medicines for human purposes for the treatment of cancer; teeth filling material; fly glue; adhesive plasters for medical purposes; medicated plasters; pharmaceutical preparations for use in discouraging the smoking habit; sterilized cloth for medical purposes, namely, sterile wound dressings; sterilized cloth containing anesthetic for medical purposes, namely, sterile wound dressings containing anesthetic for surgical purposes Medical apparatus and instruments for use in surgery; surgical apparatus and instruments for medical use; surgical apparatus and instruments for medical, dental or veterinary use; apparatus for drug administration, namely, Implantable drug delivery pumps; syringes for injection of medical substances; surgical instruments; cold and hot massage apparatus for medical purposes; veterinary ultrasound apparatus; surgical apparatus and instruments for veterinary use; orthopedic devices for diagnostic and therapeutic use; thread for medical use; suture materials; sutures; dental instruments for use in clinical diagnosis of any structural movement in dental structures, such as teeth and/or dental implants and their restorations; dental instruments, namely, probes for detecting cracks, fractures and defects; dental instruments, namely, apparatus for detecting stability of dental implants; dental apparatus for detecting stability of dental structures; dental instrument for detecting structural integrity, structural stability, defects, cracks, and fractures; reusable sanitary masks for protection against viral infection; protective face masks for medical use; gloves for medical purposes; injection needles for medical use; scalpels; support bandages; medical operating lamps; elastic tubular orthopedic bandages for supporting limbs; compression bandages; lighting fixtures for medical use; electric scalpels for surgical purposes Manufactured timber; non-metallic minerals for building or construction, as far as unprocessed; building glass; tiles and paving slabs, not of metal; non- luminous and non-mechanical signs, not of metal; advertisement columns, not of metal; monuments, not of metal; diving boards, not of metal; rocket launching platforms, not of metal; insect screens, not of metal; non-metal artificial fish reefs; prefabricated non-metal buildings; pre-fabricated non-metal pigsties; non-metal railroad ties; tiles, not of metal; works of art of stonemasonry; building stone; storage tanks of masonry; statues of stone, concrete or marble; building materials, namely, manufactured cement; asphalt, pitch and bitumen; agglomerated cork for building; outdoor blinds, not of metal and not of textile; monuments of concrete; tar; paint spraying booths, not of metal; building materials made of synthetic elements, namely, partitions being non-metallic building materials, reinforcing materials not of metal for building purposes, composite panels composed primarily of nonmetal materials, fascia and soffits Fructose for food; glucose for culinary purposes [food additives for non-industrial use]; fructo-oligosaccharide for culinary purposes; liquid fructose for culinary purposes; maltose for culinary purposes; oligosaccharides for culinary purposes; starch syrup for food for culinary purposes; grain syrup, namely, brown rice syrup for flavoring food and beverages for culinary purposes; ice; all of the foregoing comprising unfinished ingredients used in the further manufacture of finished food products

65.

PHARMACEUTICAL COMPOSITION OF FULVESTRANT HAVING IMPROVED SOLUBILITY, AND METHOD FOR PREPARING SAME

      
Application Number KR2022020858
Publication Number 2023/121232
Status In Force
Filing Date 2022-12-20
Publication Date 2023-06-29
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, Jae Young
  • Park, Sang Yeob
  • Won, Woong Roeck
  • Cho, Joong Woong

Abstract

The present invention relates to a pharmaceutical composition comprising fulvestrant and a method for preparing same and, more particularly, to a pharmaceutical composition and a method for preparing same, wherein the pharmaceutical composition comprises a combination of a specific nonionic surfactant, lecithin, castor oil, and a specific alcohol along with fulvestrant, a drug having poor solubility, thereby improving the solubility of the drug and increasing the concentration of the drug in a formulation, such that use of the pharmaceutical composition can reduce the number of administrations of the drug while showing equivalent pharmacological therapeutic effects compared to existing fulvestrant formulations, thereby reducing the inconvenience of existing formulations and increasing the convenience of patients and providers.

IPC Classes  ?

  • A61K 9/08 - Solutions
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
  • A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 31/565 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
  • A61P 35/00 - Antineoplastic agents

66.

NANOPARTICLE COMPOSITION FOR PULMONARY DRUG DELIVERY

      
Application Number KR2022021181
Publication Number 2023/121388
Status In Force
Filing Date 2022-12-23
Publication Date 2023-06-29
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Yoo, Seung Ju
  • Park, Jong Min
  • Jeong, Seung Wei

Abstract

The present invention relates to a nanoparticle composition for pulmonary drug delivery and, more specifically, to a drug delivery composition useful for specifically delivering a drug into the lungs, wherein the drug delivery composition comprises drug-bearing nanoparticles in which a complex of an anionic drug and a specific lipid is encapsulated inside nanoparticles formed by an amphiphilic block copolymer.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
  • A61K 9/00 - Medicinal preparations characterised by special physical form

67.

LIPIDS FOR DRUG DELIVERY, NANOPARTICLES COMPRISING SAME, AND COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES

      
Document Number 03241028
Status Pending
Filing Date 2022-12-23
Open to Public Date 2023-06-29
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Jong Min
  • Nam, Joung Pyo
  • Nam, Hye Yeong
  • Lee, So Jin
  • Kyung, Kyu Jin
  • Yoon, Yoo Jeong

Abstract

The present invention relates to lipids for drug delivery, nanoparticles comprising same, and a composition for drug delivery comprising the nanoparticles. More specifically, the present invention relates to: lipids useful for drug delivery since the lipids can easily form a complex with an anionic drug due to a specific structure thereof, and the complex can be encapsulated inside nanoparticles formed by an amphiphilic block copolymer; nanoparticles comprising same; and a composition for drug delivery comprising the lipids and a composition for drug delivery comprising the nanoparticles.

IPC Classes  ?

  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • C07C 231/14 - Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
  • C07C 237/16 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated

68.

NANOPARTICLE COMPOSITION FOR PULMONARY DRUG DELIVERY

      
Document Number 03241369
Status Pending
Filing Date 2022-12-23
Open to Public Date 2023-06-29
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Yoo, Seung Ju
  • Park, Jong Min
  • Jeong, Seung Wei

Abstract

The present invention relates to a nanoparticle composition for pulmonary drug delivery and, more specifically, to a drug delivery composition useful for specifically delivering a drug into the lungs, wherein the drug delivery composition comprises drug-bearing nanoparticles in which a complex of an anionic drug and a specific lipid is encapsulated inside nanoparticles formed by an amphiphilic block copolymer.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

69.

LIPIDS FOR DRUG DELIVERY, NANOPARTICLES COMPRISING SAME, AND COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES

      
Application Number KR2022021160
Publication Number 2023/121380
Status In Force
Filing Date 2022-12-23
Publication Date 2023-06-29
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Jong Min
  • Nam, Joung Pyo
  • Nam, Hye Yeong
  • Lee, So Jin
  • Kyung, Kyu Jin
  • Yoon, Yoo Jeong

Abstract

The present invention relates to lipids for drug delivery, nanoparticles comprising same, and a composition for drug delivery comprising the nanoparticles. More specifically, the present invention relates to: lipids useful for drug delivery since the lipids can easily form a complex with an anionic drug due to a specific structure thereof, and the complex can be encapsulated inside nanoparticles formed by an amphiphilic block copolymer; nanoparticles comprising same; and a composition for drug delivery comprising the lipids and a composition for drug delivery comprising the nanoparticles.

IPC Classes  ?

  • C07C 237/16 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
  • C07C 231/14 - Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
  • A61K 9/51 - Nanocapsules
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids

70.

MEDICAL THREAD HAVING POLYGONAL CROSS-SECTIONED STOPPER ON ONE END, AND MANUFACTURING METHOD FOR SAME

      
Application Number 17923388
Status Pending
Filing Date 2021-03-24
First Publication Date 2023-06-22
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, Ho Sung
  • Ryu, Dae Hui
  • Yoon, Hye Sung

Abstract

The present invention relates to a medical thread which has on one end thereof a stopper that has a polygonal cross-section, and which exhibits excellent end adhesive force and penetration resistance, and to a manufacturing method for same.

IPC Classes  ?

  • A61B 17/06 - NeedlesHolders or packages for needles or suture materials
  • A61L 17/10 - At least partly resorbable materials containing macromolecular materials
  • B29C 51/30 - Moulds

71.

ORAL TABLET COMPOSITION OF RUXOLITINIB AND METHOD FOR PREPARING SAME

      
Application Number KR2022012298
Publication Number 2023/022520
Status In Force
Filing Date 2022-08-17
Publication Date 2023-02-23
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Kim, Nam Hyuck
  • Park, Sang Yeob
  • Kim, Dong Sik

Abstract

The present invention relates to a sustained-release formulation of ruxolitinib or a pharmaceutically acceptable salt thereof which is useful for the treatment of Janus kinase-associated diseases such as myeloproliferative disorders, and a method for preparing same.

IPC Classes  ?

  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
  • A61K 9/00 - Medicinal preparations characterised by special physical form

72.

KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY, COMPRISING POLYLACTIC ACID SALT

      
Application Number 17787156
Status Pending
Filing Date 2020-12-16
First Publication Date 2023-02-09
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Kim, Sang Hoon
  • Park, Joon Young
  • Nam, Hye Yeong
  • Son, Ji Yeon

Abstract

The present invention relates to a kit for preparing a nanoparticle composition for drug delivery and, more specifically, to a kit for preparing a nanoparticle composition for drug delivery, which is designed to easily form a nanoparticle in which a drug is encapsulated by simply mixing an amphiphilic block copolymer, a cationic compound, a polylactic acid salt, and the drug that are the components of the kit.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

73.

POWDER FORMULATION FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR, COMPRISING SAME

      
Document Number 03225679
Status Pending
Filing Date 2022-07-21
Open to Public Date 2023-01-26
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Ji Hoon
  • Yoon, Hye Sung
  • Lim, Soo Mee

Abstract

The present invention relates to a powder formulation for tissue repair, a preparation method therefor, and an injectable composition for tissue repair, comprising same, and, more specifically, to: a powder formulation, a preparation method therefor, and an injectable composition for tissue repair, comprising same, the powder formulation comprising a biocompatible copolymer, which is a copolymer of a hydrophobic biocompatible polymer and a hydrophilic biocompatible polymer and forms, in an aqueous medium, micelle-type nanoparticles with an average diameter of a specific range and/or has a ratio, of a specific level or less, of the hydrophilic biocompatible polymer to the hydrophobic biocompatible polymer, being in a powder form so as to facilitate transport, storage and handling, being readily dissolved in an aqueous medium at room temperature so as to form stable nanoparticles, and allowing collagen induction to be performed without being phagocytosed by macrophages after being introduced into the body, thereby exhibiting an excellent tissue repair effect.

IPC Classes  ?

  • A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • C08G 63/664 - Polyesters containing oxygen in the form of ether groups derived from hydroxycarboxylic acids
  • C08G 65/332 - Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides or esters thereof

74.

POWDER FORMULATION FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR, COMPRISING SAME

      
Application Number KR2022010688
Publication Number 2023/003384
Status In Force
Filing Date 2022-07-21
Publication Date 2023-01-26
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Ji Hoon
  • Yoon, Hye Sung
  • Lim, Soo Mee

Abstract

The present invention relates to a powder formulation for tissue repair, a preparation method therefor, and an injectable composition for tissue repair, comprising same, and, more specifically, to: a powder formulation, a preparation method therefor, and an injectable composition for tissue repair, comprising same, the powder formulation comprising a biocompatible copolymer, which is a copolymer of a hydrophobic biocompatible polymer and a hydrophilic biocompatible polymer and forms, in an aqueous medium, micelle-type nanoparticles with an average diameter of a specific range and/or has a ratio, of a specific level or less, of the hydrophilic biocompatible polymer to the hydrophobic biocompatible polymer, being in a powder form so as to facilitate transport, storage and handling, being readily dissolved in an aqueous medium at room temperature so as to form stable nanoparticles, and allowing collagen induction to be performed without being phagocytosed by macrophages after being introduced into the body, thereby exhibiting an excellent tissue repair effect.

IPC Classes  ?

  • A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • C08G 63/664 - Polyesters containing oxygen in the form of ether groups derived from hydroxycarboxylic acids
  • C08G 65/332 - Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides or esters thereof

75.

KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY

      
Application Number 17778655
Status Pending
Filing Date 2020-11-19
First Publication Date 2023-01-19
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Kim, Sang Hoon
  • Park, Joon Young
  • Nam, Hye Yeong
  • Son, Ji Yeon

Abstract

The present invention relates to a kit for preparing a nanoparticle composition for drug delivery and, more specifically, to a kit for preparing a nanoparticle composition for drug wherein the kit is designed such that the kit does not comprise a polylactic acid salt and nanoparticles containing a drug encapsulated therein can be easily formed just by simply mixing an amphiphilic block copolymer, a cationic compound, and a drug as components of the kit.

IPC Classes  ?

  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
  • A61K 35/768 - Oncolytic viruses not provided for in groups

76.

POLYMER NANOPARTICLE COMPOSITION FOR INDUCING IMMUNITY AND PREPARATION METHOD THEREFOR

      
Application Number 17774887
Status Pending
Filing Date 2020-11-05
First Publication Date 2022-12-29
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Park, Joon Young
  • Nam, Hye Yeong
  • Cho, He Len
  • Kim, Goo Young

Abstract

Disclosed are a composition for inducing immunity against an active ingredient and a method for preparing same, the composition comprising: a nucleic acid, a polypeptide, or a combination thereof as the active ingredient; a cationic compound; an amphiphilic block copolymer; and a polylactate, wherein the active ingredient is encapsulated in a nanoparticle structure formed by the amphiphilic block copolymer and the polylactate.

IPC Classes  ?

  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 47/50 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61P 35/00 - Antineoplastic agents

77.

COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES NOT CONTAINING AMPHIPHILIC POLYMER

      
Document Number 03216941
Status Pending
Filing Date 2022-04-29
Open to Public Date 2022-11-03
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Kim, Go Eun
  • Park, Joon Young

Abstract

The present invention relates to a composition forming nanoparticles for delivering a drug, and more specifically, to a composition for drug delivery comprising nanoparticles containing cationic compounds and a polylactic acid salt but not containing an amphiphilic polymer, wherein a drug can easily be incorporated into the nanoparticles by simply mixing the drug therewith, and furthermore, cell delivery efficiency of the drug can be further increased compared to nanoparticles containing an amphiphilic polymer.

IPC Classes  ?

78.

KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS

      
Document Number 03216946
Status Pending
Filing Date 2022-04-29
Open to Public Date 2022-11-03
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Kim, Go Eun
  • Park, Joon Young

Abstract

The present invention relates to a kit for preparing nanoparticles containing a drug and, more specifically, to a kit for preparing drug-containing nanoparticles, the kit enabling a drug to be easily contained in nanoparticles by simple mixing only, preferably, in a specific weight ratio, the drug and nanoparticles containing a cationic compound and a polylactate, as kit constituent components comprising no amphiphilic polymers,, and being designed to enable the efficiency of drug delivery into cells to be greater than that of a kit comprising an amphiphilic polymer.

IPC Classes  ?

79.

KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS

      
Application Number KR2022006174
Publication Number 2022/231374
Status In Force
Filing Date 2022-04-29
Publication Date 2022-11-03
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Kim, Go Eun
  • Park, Joon Young

Abstract

The present invention relates to a kit for preparing nanoparticles containing a drug and, more specifically, to a kit for preparing drug-containing nanoparticles, the kit enabling a drug to be easily contained in nanoparticles by simple mixing only, preferably, in a specific weight ratio, the drug and nanoparticles containing a cationic compound and a polylactate, as kit constituent components comprising no amphiphilic polymers,, and being designed to enable the efficiency of drug delivery into cells to be greater than that of a kit comprising an amphiphilic polymer.

IPC Classes  ?

80.

COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES NOT CONTAINING AMPHIPHILIC POLYMER

      
Application Number KR2022006177
Publication Number 2022/231375
Status In Force
Filing Date 2022-04-29
Publication Date 2022-11-03
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, So Jin
  • Kim, Go Eun
  • Park, Joon Young

Abstract

The present invention relates to a composition forming nanoparticles for delivering a drug, and more specifically, to a composition for drug delivery comprising nanoparticles containing cationic compounds and a polylactic acid salt but not containing an amphiphilic polymer, wherein a drug can easily be incorporated into the nanoparticles by simply mixing the drug therewith, and furthermore, cell delivery efficiency of the drug can be further increased compared to nanoparticles containing an amphiphilic polymer.

IPC Classes  ?

81.

POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR

      
Application Number 17266241
Status Pending
Filing Date 2019-08-07
First Publication Date 2022-08-18
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Choi, Joung Woo
  • Kim, Sang Hoon
  • Nam, Hye Yeong
  • Cho, Helen
  • Yun, Min Hyuk
  • Kim, Goo Young
  • Lee, So Jin

Abstract

The present invention relates to: a virus-containing pharmaceutical composition, which comprises, as an active ingredient, a virus for treating or preventing disease; and a preparation method therefor.

IPC Classes  ?

  • A61K 35/768 - Oncolytic viruses not provided for in groups
  • A61K 9/51 - Nanocapsules
  • A61K 35/763 - Herpes virus
  • A61K 35/766 - Rhabdovirus, e.g. vesicular stomatitis virus
  • A61K 35/761 - Adenovirus
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61K 47/30 - Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
  • A61K 9/107 - Emulsions
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 9/00 - Medicinal preparations characterised by special physical form

82.

MEDICAL SUTURE AND METHOD FOR PRODUCING SAME

      
Application Number 17416755
Status Pending
Filing Date 2020-03-27
First Publication Date 2022-08-18
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, Ho Sung
  • Ryu, Dae Hui
  • Yoon, Hye Sung

Abstract

In order to provide a means for fixing an end of a medical suture to skin tissue in a short time and thereby reduce an operation time, the present invention provides: a medical suture comprising a main body, which extends in the length direction, and a stopper, which is at one end of the main body and has a larger cross section than the main body; and a method for producing same.

IPC Classes  ?

  • A61B 17/04 - Surgical instruments, devices or methods for closing wounds or holding wounds closedAccessories for use therewith for suturing woundsHolders or packages for needles or suture materials
  • A61B 17/06 - NeedlesHolders or packages for needles or suture materials
  • A61L 17/10 - At least partly resorbable materials containing macromolecular materials

83.

MONOFIX

      
Application Number 1677630
Status Registered
Filing Date 2022-06-20
Registration Date 2022-06-20
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Anaesthetic drapes; suture apparatus; sutures; suture materials; suturing instruments; overhead operating room theater lights; tubular elastic bandages for supporting limbs; compression bandages; scalpels; surgical drapes; surgical sutures; thread, surgical; medical drapes; thread for medical use; lighting for medical use; injection needles for medical use; support bandages for medical purposes; electric scalpels; injection needles; support bandages.

84.

Apparatus and method for manufacturing fibrous web, fibrilla fiber aggregate, or nonwoven fabric, and fibrous web, fibrilla fiber aggregate, or nonwoven fabric manufactured thereby

      
Application Number 17613560
Grant Number 12084798
Status In Force
Filing Date 2019-06-12
First Publication Date 2022-08-04
Grant Date 2024-09-10
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Yoon, Hye Sung
  • Kim, Jin Su

Abstract

The present invention relates to an apparatus for manufacturing a fibrous web, a fibrilla fiber aggregate, or a nonwoven fabric by using a woven fabric, a method for manufacturing a fibrous web, a fibrilla fiber aggregate, or a nonwoven fabric by using the apparatus, and a fibrous web, a fibrilla fiber aggregate, or a nonwoven fabric manufactured by the method, especially, a fibrous web, a fibrilla fiber aggregate, or a nonwoven fabric for use in a hemostatic agent or an anti-adhesive agent.

IPC Classes  ?

  • D04H 17/12 - Multi-roller apparatus
  • A61L 24/08 - Polysaccharides
  • A61L 31/04 - Macromolecular materials
  • D04H 1/44 - Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties the fleeces or layers being consolidated by mechanical means, e.g. by rolling
  • D04H 1/70 - Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres

85.

MONOFIX

      
Application Number 1674774
Status Registered
Filing Date 2022-06-20
Registration Date 2022-06-20
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Bioabsorbable hemostatics for medical purposes; vulnerary sponges; gauze for medical purposes; adhesive plasters for medical purposes; dressings, medical; cotton for medical purposes; adhesive bands for medical purposes; dermatological pharmaceutical products; pharmaceutical preparations for skin care.

86.

MONOFIX

      
Serial Number 79347287
Status Registered
Filing Date 2022-06-20
Registration Date 2023-10-10
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Anaesthetic apparatus in the nature of drapes; suture apparatus; sutures; suture materials; suturing instruments; overhead operating room theater lights; tubular elastic bandages for supporting limbs; compression bandages; scalpels; surgical drapes; surgical sutures; thread, surgical; medical drapes; thread for medical use; Lighting for medical use, namely, light emitting diode (LED) apparatus for lighting, incorporated into medical instruments; injection needles for medical use; support bandages for medical purposes; electric scalpels; injection needles; support bandages

87.

MONOFIX

      
Serial Number 79346116
Status Registered
Filing Date 2022-06-20
Registration Date 2023-10-10
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Bioabsorbable hemostatics in the nature of absorbable surgical suture for medical purposes; vulnerary sponges; gauze for medical purposes; adhesive plasters for medical purposes; dressings, medical; cotton for medical purposes; adhesive bands for medical purposes; dermatological pharmaceutical products; pharmaceutical preparations for skin care

88.

METHOD FOR PREPARING POLYMERIC MICELLE NANOPARTICLES CAPABLE OF SHORTENING RECONSTRUCTION TIME

      
Application Number KR2021018630
Publication Number 2022/124818
Status In Force
Filing Date 2021-12-09
Publication Date 2022-06-16
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Kim, Dong Sik
  • Kim, Bong Oh
  • Lee, Jae Young
  • Cho, Joong Woong

Abstract

The present invention relates to a method for preparing polymeric micelle nanoparticles and, more particularly, to a method for preparing polymeric micelle nanoparticles, in which, by preparing drug-containing nanoparticles under specific conditions by using an amphiphilic block copolymer having a certain level of low molecular weight, the nanoparticles are rapidly reconstructed in an aqueous medium such as physiological saline, have excellent stability and uniformity, and are capable of providing a formulation having a reduced amount of related substances.

IPC Classes  ?

  • C08J 3/12 - Powdering or granulating
  • C08L 101/00 - Compositions of unspecified macromolecular compounds
  • C08L 71/00 - Compositions of polyethers obtained by reactions forming an ether link in the main chainCompositions of derivatives of such polymers
  • C08L 67/04 - Polyesters derived from hydroxy carboxylic acids, e.g. lactones
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/51 - Nanocapsules
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

89.

OLAPARIB SOLID DISPERSION COMPOSITION WITH IMPROVED STABILITY AND BIOAVAILABILITY

      
Application Number KR2021017964
Publication Number 2022/119300
Status In Force
Filing Date 2021-12-01
Publication Date 2022-06-09
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lim, Hye Jung
  • Park, Sang Yeob
  • Won, Woong Roeck

Abstract

The present invention relates to an olaparib solid dispersion composition having improved stability and bioavailability, and more specifically, to: an olaparib solid dispersion; and an oral composition comprising same, wherein the olaparib solid dispersion includes olaparib, which is a poorly soluble drug, a polymethacrylate copolymer, and a cellulose-based polymer as essential components, has excellent storage stability and thermal stability, and exhibits uniform drug releasability under all of the various pH conditions inside the body.

IPC Classes  ?

  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 31/502 - PyridazinesHydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
  • A61P 35/00 - Antineoplastic agents

90.

SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION OF FULVESTRANT AND METHOD FOR PREPARING SAME

      
Application Number KR2021018233
Publication Number 2022/119383
Status In Force
Filing Date 2021-12-03
Publication Date 2022-06-09
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, Jae Young
  • Kim, Dong Sik
  • Yun, Min Hyuk

Abstract

The present invention relates to a sustained-release pharmaceutical composition comprising fulvestrant and a method for preparing same and, more specifically, to a pharmaceutical composition and a method for preparing same, in which, by comprising, in the pharmaceutical composition, a combination of lecithin, a C2-C5 alcohol, and polyethylene glycol, along with fulvestrant, which is a poorly soluble drug, the solubility of the drug is improved, thus increasing the concentration of the drug in a formulation, and thus, pharmacological therapeutic effects equivalent to those of conventional fulvestrant formulations are exhibited and the number of administrations can be reduced, thus improving the inconvenience of conventional formulations and increasing the convenience of patients and providers.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 31/565 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
  • A61P 35/00 - Antineoplastic agents

91.

PHARMACEUTICAL COMPOSITION CONTAINING ANIONIC DRUG, AND PREPARATION METHOD THEREFOR

      
Application Number 17572195
Status Pending
Filing Date 2022-01-10
First Publication Date 2022-04-28
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Nam, Hye Yeong
  • Kim, Bong-Oh
  • Seo, Min-Hyo
  • Son, Ji-Yeon
  • Choi, Ji-Hye
  • Kim, Sang Hoon

Abstract

Disclosed are a pharmaceutical composition for anionic drug delivery, and a preparation method therefor, the pharmaceutical composition for anionic drug delivery containing: an anionic drug as an active ingredient; a cationic compound; an amphiphilic block copolymer; and a polylactate, wherein the anionic drug formed a complex with the cationic lipid, and the complex is encapsulated within a micelle structure formed by the amphiphilic block copolymer and the polylactate.

IPC Classes  ?

  • A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
  • A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
  • A61K 9/107 - Emulsions
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

92.

COMPOSITION FOR HYDROGEL FORMATION, HYDROGEL FORMED BY PHOTO-CROSSLINKING SAME, AND METHOD FOR PREPARING HYDROGEL

      
Application Number KR2021010330
Publication Number 2022/031073
Status In Force
Filing Date 2021-08-05
Publication Date 2022-02-10
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Chang, Ji Hyun
  • Kim, Hyung Hwan
  • Yoon, Hye Sung

Abstract

The present invention relates to a composition for hydrogel formation, a hydrogel formed by photo-crosslinking same, and a method for preparing the hydrogel and, more specifically, to a composition which comprises a photo-initiator and a polyglutamic acid polymer having a photo-crosslinkable functional group introduced thereto and is capable of forming a hydrogel in real time through photo-crosslinking, to a hydrogel which is formed by photo-crosslinking the composition and can be utilized as a tissue adhesive, a surgical sealant, anti-adhesive agent, or the like due to excellent biocompatibility, superior adhesive strength in wet environments, flexibility, and ease of use, and to a method for preparing the hydrogel.

IPC Classes  ?

  • C08L 77/04 - Polyamides derived from alpha-amino carboxylic acids
  • C08G 63/08 - Lactones or lactides
  • C08G 63/91 - Polymers modified by chemical after-treatment
  • C08J 3/28 - Treatment by wave energy or particle radiation
  • C08J 3/24 - Crosslinking, e.g. vulcanising, of macromolecules
  • A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
  • A61L 24/06 - Surgical adhesives or cementsAdhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
  • A61L 31/14 - Materials characterised by their function or physical properties
  • A61L 31/04 - Macromolecular materials

93.

TABLET CONTAINING PAZOPANIB AS ACTIVE INGREDIENT, AND PREPARATION METHOD THEREFOR

      
Application Number KR2021008257
Publication Number 2022/005199
Status In Force
Filing Date 2021-06-30
Publication Date 2022-01-06
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Kim, Nam Hyuck
  • Park, Sang Yeob
  • Lee, Sa Won

Abstract

The present invention relates to a tablet containing, as an active ingredient, pazopanib which is a poorly soluble drug, and, more specifically, to: a pazopanib tablet capable of exhibiting dissolution and pharmacodynamic properties greater than or equal to those of a conventional tablet product and, simultaneously, exhibiting uniform internal absorption by having a small deviation in disintegration time; and a method for preparing same.

IPC Classes  ?

  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 31/506 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
  • A61P 35/00 - Antineoplastic agents

94.

MEDICAL THREAD HAVING POLYGONAL CROSS-SECTIONED STOPPER ON ONE END, AND MANUFACTURING METHOD FOR SAME

      
Application Number KR2021003623
Publication Number 2021/241868
Status In Force
Filing Date 2021-03-24
Publication Date 2021-12-02
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, Ho Sung
  • Ryu, Dae Hui
  • Yoon, Hye Sung

Abstract

The present invention relates to a medical thread which has on one end thereof a stopper that has a polygonal cross-section, and which exhibits excellent end adhesive strength and penetration resistance, and to a manufacturing method for same.

IPC Classes  ?

  • A61B 17/06 - NeedlesHolders or packages for needles or suture materials
  • A61L 17/10 - At least partly resorbable materials containing macromolecular materials
  • B29C 51/08 - Deep-drawing or matched-mould forming, i.e. using mechanical means only
  • B29C 51/30 - Moulds
  • B29C 51/42 - Heating or cooling
  • A61B 17/04 - Surgical instruments, devices or methods for closing wounds or holding wounds closedAccessories for use therewith for suturing woundsHolders or packages for needles or suture materials
  • A61B 17/00 - Surgical instruments, devices or methods
  • B29L 31/00 - Other particular articles

95.

MEDICAL THREAD HAVING POLYGONAL CROSS-SECTIONED STOPPER ON ONE END, AND MANUFACTURING METHOD FOR SAME

      
Document Number 03176982
Status Pending
Filing Date 2021-03-24
Open to Public Date 2021-12-02
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Lee, Ho Sung
  • Ryu, Dae Hui
  • Yoon, Hye Sung

Abstract

The present invention relates to a medical thread which has on one end thereof a stopper that has a polygonal cross-section, and which exhibits excellent end adhesive force and penetration resistance, and to a manufacturing method for same.

IPC Classes  ?

  • A61B 17/04 - Surgical instruments, devices or methods for closing wounds or holding wounds closedAccessories for use therewith for suturing woundsHolders or packages for needles or suture materials
  • A61B 17/06 - NeedlesHolders or packages for needles or suture materials
  • A61L 17/10 - At least partly resorbable materials containing macromolecular materials
  • B29C 51/08 - Deep-drawing or matched-mould forming, i.e. using mechanical means only
  • B29C 51/30 - Moulds

96.

POWDER TYPE HEMOSTATIC COMPOSITION AND METHOD FOR PREPARING THE SAME

      
Application Number 16973215
Status Pending
Filing Date 2020-10-30
First Publication Date 2021-12-02
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Kim, Hyun Kyoon
  • Huh, Beom Kang
  • Yoon, Hye Sung
  • Ko, Suk Yen

Abstract

The present invention relates to a powder type hemostatic composition and method for preparing the same, and more specifically, to powder aggregate having porosity obtained by combining powder of biocompatible hemostatic material with a binder and a method for preparing the same, and a powder type hemostatic composition which comprises the powder aggregate and shows improved hemostatic performance as compared with simple powder hemostatic agents, and can be used to a large surface area for hemostasis, or to narrow, thin or other sites to which approach for hemostasis is difficult.

IPC Classes  ?

  • A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
  • C08L 1/02 - CelluloseModified cellulose

97.

Medical thread

      
Application Number 29716992
Grant Number D0936829
Status In Force
Filing Date 2019-12-13
First Publication Date 2021-11-23
Grant Date 2021-11-23
Owner Samyang Holdings Corporation (Republic of Korea)
Inventor
  • Ryu, Daehui
  • Lapko, Ianina
  • Lee, Hosung

98.

Medical thread

      
Application Number 29730263
Grant Number D0936830
Status In Force
Filing Date 2020-04-02
First Publication Date 2021-11-23
Grant Date 2021-11-23
Owner Samyang Holdings Corporation (Republic of Korea)
Inventor
  • Lee, Hosung
  • Choi, Hwanseok

99.

Mucoadhesive pharmaceutical composition and preparation method therefor

      
Application Number 17389132
Grant Number 11839684
Status In Force
Filing Date 2021-07-29
First Publication Date 2021-11-18
Grant Date 2023-12-12
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Sang Yeob
  • Yoon, Jong Won

Abstract

Disclosed is a mucoadhesive pharmaceutical composition comprising a poly-ionic complex of chitosan and a polyacrylic acid polymer. As an oral formulation, the composition has the extended retention time in the gastrointestinal tract by its mucoadhesive and swelling properties, which is useful as sustained release formulations, retentive formulations of active ingredients with limited absorption regions, and active ingredients with pH dependent solubility.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/32 - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
  • A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
  • A61K 47/42 - ProteinsPolypeptidesDegradation products thereofDerivatives thereof, e.g. albumin, gelatin or zein
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

100.

ORAL TABLET COMPOSITION OF POMALIDOMIDE AND METHOD FOR PREPARING SAME

      
Application Number KR2021003646
Publication Number 2021/194253
Status In Force
Filing Date 2021-03-24
Publication Date 2021-09-30
Owner SAMYANG HOLDINGS CORPORATION (Republic of Korea)
Inventor
  • Park, Sang Yeob
  • Lee, Sa Won

Abstract

The present invention relates to an oral tablet composition containing pomalidomide and a method for preparing same and, more specifically, to a composition in a tablet form, in which physicochemical equivalence with existing pomalidomide formulations prepared in a hard capsule is shown, equivalence is secured in a non-clinical test and a bioequivalence test as well and thus equivalent pharmacological therapeutic effects are shown, and ease of administration, handling and safety are further improved, and to a method for preparing same.

IPC Classes  ?

  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 9/28 - DrageesCoated pills or tablets
  • A61K 31/454 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
  • A61P 35/00 - Antineoplastic agents
  1     2     3        Next Page